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ABSTRACT
Acute traumatic joint injury in young adults leads to an increased risk for the
development of osteoarthritis (OA) later in life irrespective of surgical intervention to stabilize
the injured joint. Although the mechanism by which injury leads to joint degeneration remains to
be elucidated, several injury-related factors may contribute to the development of OA. These
factors include but are not limited to altered mechanical loading and initiation of a cellular
response in cartilage or other joint tissues at the time of the injury. Three in vitro models of joint
injury were investigated to separately evaluate the effects on cartilage of mechanical overloading
and damage to joint capsule and synovial lining. Models of injury included (1) mechanical injury
lto cartilage explants alone, (2) co-culture of normal cartilage explants with an excised specimen
of joint capsule tissue, and (3) co-culture of mechanically injured cartilage explants with excised
joint capsule tissue. These models have been shown previously to result in matrix damage and
decreased biosynthesis by the chondrocytes.
We measured gene expression levels of matrix molecules and matrix proteases and found
them to be expressed in control cartilage at levels ranging over five orders of magnitude, and to
be differentially regulated in these three models of joint injury. Expression of matrix molecules
including collagen II and aggrecan were unaffected by injurious compression or co-culture with
joint capsule tissue during the first 24 hours; however, the combination of injurious compression
followed by co-culture resulted in a -50% decrease in expression by 24 hours. Matrix proteases
aggrecanase-2 (ADAMTS-5) and stromelysin (MMP-3) showed increased expression of 40-250-
fold by 12 hours following injurious compression and 6-12-fold during 24 hours of co-culture
with joint capsule tissue. Aggrecanase-1 (ADAMTS-4) and collagenase-3 (MMP-13) showed
larger magnitude increases in expression during co-culture (6-8-fold; 6-24 hours) compared to
injurious compression (2-4-fold; 6-24 hours). Expression of transcription factors, c-fos and c-jun,
was rapidly increased by injurious compression (40-100-fold within one hour) but was less
affected by co-culture with joint capsule tissue (increased 3-5-fold; 1-24 hours). Expression level
results displayed a general trend toward matrix degradation in the models of joint injury with
specific differences apparent between the models. Analysis of matrix protein fragments in the
same injury models showed cleavage of aggrecan at the aggrecanase site in the interglobular
domain by 16 days following injurious compression and during co-culture with joint capsule
tissue. Equilibrium and dynamic stiffness of cartilage explants were decreased by 30-35%
immediately after injurious compression but were unaffected through 16 days of co-culture with
joint capsule tissue. Specific changes in gene expression and activity of matrix proteases
observed in these injury models may be indicative of some of the molecules responsible in the
initial phase of cartilage degradation observed clinically following joint injury.
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CHAPTER 1: INTRODUCTION
1.1. THE KNEE
The knee occurs at the junction of three bones: the femur, tibia, and patella. At the ends
of the bones is a layer of articular cartilage, which cushions the joint, distributes load to the
underlying bone, provides a low friction surface for movement, and contributes to lubrication
(Ross, 2003). Additional cushioning is provided by the menisci, two C-shaped pieces of cartilage
located between the femur and the tibia. There are four main ligaments in the knee serving to
stabilize the joint. These are the anterior cruciate ligament (ACL), posterior cruciate ligament
(PCL), medial collateral ligament (MCL), and lateral collateral ligament (LCL). There are two
main muscle groups responsible for extension, quadriceps, and flexion, hamstring. The knee is
the largest synovial joint in the body. During level walking, the force across the tibiofemoral
joint ranges between two and four times body weight while the force across the patellofemoral
joint does not exceed 50% of body weight. Peak force transmission across the joint increases as
damage occurs to the menisci, articular cartilage, and subchondral bone (Standring, 2005).
1.2. CARTILAGE STRUCTURE
Cartilage is an avascular tissue composed of chondrocytes in an extensive extracellular
matrix, which is produced and maintained by the cells. The cartilage matrix is well adapted for
weight bearing and is 60-80% water. Additionally, the matrix includes proteoglycans, type II
collagen, and hyaluronic acid. Cartilage extracellular matrix permits diffusion of substances
between blood vessels in the surrounding connective tissue and the chondrocytes, maintaining
the viability of the tissue. The matrix of hyaline cartilage appears glassy in the living state
explaining its name derived from the Greek hyalos meaning glass. Chondrocytes are located
throughout the cartilage matrix in spaces called lacunae. When damaged, chondrocytes have a
limited capacity to repair the matrix (Ross, 2003).
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Many different types of collagen are expressed in articular cartilage to form the complex
fibrillar structure of the collagen network. This network varies in structure from the articular
surface to the deep zones of cartilage and from the pericellular space surrounding chondrocytes
to the interterritorial matrix. In articular cartilage, the collagen network is composed
predominantly of Type II collagen fibrils present as heteropolymers with collagen IX molecules
covalently linked to the surface of the fibrils and collagen XI forming a filamentous template at
the fibril core. Collagen XI serves to regulate fibril diameter through retained N-propeptide
domains. In addition to the abundant collagen fibrils, Type III collagen is found in normal and
osteoarthritic human articular cartilage, colocalized with collagen II. Type VI collagen comprises
<1%o of the collagen in the matrix and is concentrated around chondrocytes. Types XII and XIV
collagens are also present in the matrix of cartilage but are not covalently bound to collagen
fibrils (Eyre, 2004).
In addition to collagen, the extracellular matrix of articular cartilage is composed of a
wide variety of proteoglycans. Aggrecan is the most abundant proteoglycan in cartilage and is
largely responsible for the ability of the tissue to resist compression. Aggrecan has an amino-
terminal globular domain that interacts with hyaluronan and link protein to form large,
multimolecular complexes. Chondroitin sulfate and keratin sulfate chains are covalently attached
along the aggrecan core protein in three glycosaminoglycan attachment domains (Roughley,
2001).
The cartilage matrix also contains other proteoglycans that do not form aggregates, as
well as noncollagenous and nonproteoglycan-linked glycoproteins. These small regulatory and
structural proteins influence interactions between the chondrocytes and the matrix and can be
valuable clinically as markers of cartilage turnover and degradation. Examples of such proteins
are anchorin CII, tenascin, and fibronectin, which help anchor chondrocytes to the matrix (Ross,
2003).
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Because chondrocytes are dispersed, the matrix acts as a signal transducer for the
embedded cells; loads applied to cartilage create mechanical, electrical, and chemical signals that
direct cellular synthetic activity. Normal matrix turnover relies on the ability of chondrocytes to
detect changes in matrix composition and respond to these changes by synthesizing appropriate
new molecules. As the body ages, matrix composition changes and chondrocytes loose their
ability to respond to their environment (Ross, 2003).
11.3. JOINT CAPSULE, SYNOVIUM, LIGAMENTS
The joint capsule is a fibrous membrane of variable thickness extending from the patellar
tendon to the collateral ligament on both sides of the knee (Standring, 2005). The loose
connective tissue of the capsule is composed of sparse collagen fibers, proteoglycans, and
hyaluronic acid. The matrix allows diffusion of oxygen and nutrients from the small vessels
present throughout tissue and diffusion of carbon dioxide and metabolic waste back to vessels.
Many of the cells occurring in loose connective tissue are transient wandering cells that migrate
from local blood vessels in response to stimuli. This tissues serves as a site of inflammatory and
immune reactions and can undergo considerable swelling (Ross, 2003).
The internal surface of the capsule is lined by a thin tissue known as the synovium. The
synovial membrane of the knee is the most extensive and complex synovium in the body. It
extends several centimeters above the patella and is separated from the patellar tendon by an
infrapatellar fat pad. The synovium covers the fat pad and projects into the joint. At the sides of
the joint, the synovial membrane descends from the femur and lines the capsule as far as the
menisci, whose surfaces have no synovial lining. The cruciate ligaments are partially surrounded
by synovial membrane. Following acute or chronic trauma, the synovial membrane can become
thickened and inflamed (Standring, 2005).
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Cruciate ligaments, termed cruciate because they cross, are located in the center of the
knee joint. The anterior cruciate ligament (ACL) is attached to the anterior intercondylar area of
the tibia and ascends, twisting on itself, to attach high of the lateral femoral condyle. The
posterior cruciate ligament (PCL) is attached to the posterior tibia extending to the medial
femoral condyle. The PCL is thicker and stronger than the ACL and its rupture is less common
and usually better tolerated (Standring, 2005). Ligaments are dense connective tissue and consist
mainly of densely packed collagen fibers arranged in parallel. Fibroblasts that produce and
maintain the fibers are packed and aligned between fiber bundles (Ross, 2003).
1.4. OSTEOARTHRITIS
Arthritis and chronic joint symptoms occur in more than 70 million people in the United
States or one out of every three adults. Arthritis is the leading cause of disability in the United
States with costs for care reaching nearly $22 billion in 1995 with additional costs of $60 billion
attributed to loss of productivity (Praemer, 1999). The prevalence of arthritis and chronic joint
symptoms increases with age and in 2001 occurred in 19% of people age 19-44, 42% of people
age 44-64, and 59% of those over 65 years old. Prevalence of arthritis also increases with
increasing body weight occurring in 27% of underweight and normal weight individuals, 34% in
those who are overweight, and 45% of obese people (Bolen, 2002).
Osteoarthritis (OA), a degenerative disease in which the cartilage in the joint is degraded
and joint movement becomes painful, is the most common form of arthritis and occurs in a
variety of joints including the knee, hip, hand/fingers, spine, and foot. Symptomatic OA occurs
in. the knee in 6% of adults in the hip in 3% of adults (Felson, 2000). It remains unclear whether
OA is one disease or many disorders with a similar final pathway (Felson, 2000). Clinically, the
most compelling definition of the disease is one that combines the pathology of the disease with
pain during joint use (many people with radiographic and pathologic changes of OA do not
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experience symptoms). The cause of pain in OA is unknown. Pathology of osteoarthritis involves
the whole joint and includes focal and progressive hyaline cartilage loss with concomitant
changes in bone underneath the cartilage including development of marginal outgrowths,
osteophytes, and increased thickness of the bony envelope (bony sclerosis). Soft tissue structures
in and around the joint are also affected including modest inflammation of the synovium,
weakening of the bridging muscle in the joint, and loosening of the ligaments. Clinically,
symptoms in a joint affected by OA may include pain, inflammation, swelling, stiffness, loss of
range of motion, and weakness.
Treatment of OA remains challenging with no cure currently available for the disease.
Physical activity can decrease pain, improve function, and delay disability caused by OA. In
overweight patients, disease progression can be slowed by weight loss. NSAIDS (non-steroidal
anti-inflammatory drugs) are used to reduce pain and inflammation in the joint. Dietary
supplements including glucosamine and chondroitin sulfate are used with reported success.
Physical therapy to improve flexibility and strengthen muscle is also used as a treatment for OA.
In the end stage of disease, surgery is often the only option. Arthroscopy is performed to remove
bone spurs, cysts, damaged lining, or loose fragments from the joint. Other surgical options
include joint fusion, which eliminates joint flexibility and joint replacement, which maintains
joint flexibility but can be problematic over time.
1.5. CLINICAL JOINT INJURY
In addition to age and body weight, joint injury is a well established risk factor for the
development of OA particularly in the knee and hip (Davis, 1989; Roos, 1995; Gelber, 2000).
Risk for OA is not affected by surgical intervention to stabilize the joint following ACL rupture
(Lohmander, 2004; von Porat, 2004). A prospective study performed at John's Hopkins Medical
School showed by 65 years of age the cumulative incidence of knee OA was 14% in participants
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who had a knee injury during adolescence and young adulthood compared to 6% in those who
did not (Gelber, 2000). Joint injuries typically include anterior cruciate ligament (ACL) or
meniscus tears with ACL tears most common in patients under 30 and meniscus tears most
common over the age of 30 (Roos, 1995). A study of a group of female soccer players who
sustained an ACL injury showed by 12 years after injury (mean age 31 years at assessment),
radiographic changes in knee index occurred in 82% with 51% fulfilling criteria for radiographic
knee OA. Of these, 75% had symptoms affecting their knee-related quality of life and 42% had
symptomatic, radiographic knee OA (Lohmander, 2004).
Clinical studies of knee injury have shown marked changes in the joint environment.
Analysis of synovial fluid shows increased levels of matrix degrading enzymes (Lohmander,
1993a), increased markers of matrix turnover (Lohmander, 1993a; Lohmander, 1993b;
I,ohmander, 1999; Lohmander, 2003), and elevated levels of inflammatory cytokines (Irie, 2003)
in injured joints compared to synovial fluid from uninjured controls. The origin of these factors
in the synovial fluid is unknown and may include one or more of cartilage, synovium, ligament,
tendon, and bone. It is likely that this altered joint environment is involved as either a cause or an
effect in the pathology of OA development.
1.6. JOINT INJURY MODEL SYSTEMS
To study joint injury in more detail, in vivo and in vitro model systems have been
developed. In vivo animal studies of joint injury have shown changes in both the cartilage and
synovium after transection of the anterior cruciate ligament (ACLT). The ACLT model of joint
injury results in changes analogous to those seen during OA progression including full-thickness
loss of articular cartilage, osteophyte formation, cartilage surface fibrillation, chondrocyte
cloning, hyperplasia of synovial lining, mononuclear cell infiltration, and joint capsule fibrosis
(Brandt, 1991). In addition to gross morphological changes in the joint, ACLT leads to changes
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in expression of matrix molecules and enzymes in cartilage and synovium (Takahashi, 1999; Le
Graverand, 2002). Recent studies have specifically shown aggrecanase-2 to be responsible for
cartilage degradation in mouse models of OA (Glasson, 2005; Stanton, 2005).
In vitro injury models include impact loading of articular cartilage and co-culture of
cartilage with damaged synovium or joint capsule tissue to model soft tissue tears. Models in
which cartilage tissue is overloaded result in cell and tissue damage including cell death (Quinn,
11998; Chen, 1999; Torzilli, 1999; Loening, 2000; Chen, 2001; D'Lima, 2001; Kurz, 2001;
Thibault, 2002; Patwari, 2003; DiMicco, 2004). Co-culture of cartilage with synovial or joint
capsule tissue also results in cell and tissue damage in the cartilage (Fell and Jubb, 1977; Jubb
amd Fell, 1980; Vankemmelbeke, 1999; Patwari, 2001). The combination of mechanical injury of
cartilage followed by co-culture with joint capsule results in further reduction in biosynthesis
than that measured after injury or co-culture alone (Patwari, 2001).
1.7. THESIS OBJECTIVES
We sought to gain further understanding of the mechanisms involved in joint injury by
studying the effects on chondrocytes of established in vitro models of injury to cartilage. We
hypothesized that specific changes would occur at the level of gene expression in response to
injurious stimuli. Real-time PCR was used to quantitatively measure gene expression levels of 24
genes central to cartilage matrix maintenance in free swelling control cartilage explants. We then
measured expression levels of these genes at six time points within the first 24 hours in multiple
models of joint injury. Data from the mechanical injurious compression model of cartilage injury
was compared to data from the injury model involving co-culture of cartilage with joint capsule
tissue. Additionally, effects of these two stimuli applied individually were compared to measured
gene expression changes in response to the combination of injurious compression followed by
co-culture with joint capsule tissue. This experimental design made possible determination of
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specific molecules that are affected by injurious compression, co-culture, or the combination of
these stimuli. We next sought to measure protein levels and activity of catabolic enzymes in the
joint injury models. We hypothesized that matrix damage observed in these injury models was
the result of activity of specific catabolic enzymes able to cleave cartilage extracellular matrix
molecules. As well, we sought to determine the effect on equilibrium and dynamic stiffness of
cartilage tissue explants in each of the injury models. Overall, the goal of this project was to
determine if there is a general shift in cellular activity toward matrix repair or degradation
following events of joint injury and to identify specific enzymes that may be involved in these
processes.
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CHAPTER 2: MECHANICAL INJURY OF CARTILAGE EXPLANTS
CAUSES SPECIFIC TIME DEPENDENT CHANGES IN CHONDROCYTE
GENE EXPRESSION
2.1. INTRODUCTION
Acute traumatic joint injury in young adults leads to an increased risk for the
development of osteoarthritis (OA) later in life (Davis, 1989; Gelber, 2000; von Porat, 2004)
despite efforts to intervene in this process by surgically stabilizing injured joints (Roos, 1995).
Although the mechanism by which injury leads to tissue degeneration remains to be elucidated,
several injury-related factors may contribute to the development of OA. These factors include
but are not limited to instability in the joint due to ligament, tendon, or meniscus tear, and/or
initiation of a cellular response in cartilage or other joint tissues at the time of the injury.
Previous clinical studies have shown an increase in MMP-3 and TIMP-1 protein levels as
well as an increase in proteoglycan and type II collagen fragments in the synovial fluid of
patients following a tear in the anterior cruciate ligament (ACL) or meniscus from 1 day to 20
years after the injury (Lohmander, 1994; Lohmander, 2003). During the first week after ACL
injury, there was also a significant increase in synovial fluid levels of TNF-a and IL-10. By
three weeks after injury, the levels of these cytokines decreased to those seen in samples from
patients with chronic arthritis (Irie, 2003). Gene expression studies comparing normal and OA
cartilage have shown upregulation of MMP-13 in late-stage OA, while MMP-3 is downregulated
(Bau, 2002); as well, BMP-2 is increased in OA cartilage and co-localizes with newly
synthesized procollagen II suggesting anabolic remodeling of the tissue (Fukui, 2003).
Using the lapine ACL transection model to study the pathogenesis of OA in vivo,
investigators have found an increase in MMP-3 expression level after 9 weeks (Takahashi,
1999), and location specific changes in mRNA levels of several genes after 3 and 8 weeks (Le
Graverand, 2002). Expression of collagen II, aggrecan, biglycan, MMP-1, MMP-3, MMP-13,
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and TIMP- I1 all increased during the development of OA in this animal model, while decorin and
fibromodulin showed decreased expression (Le Graverand, 2002).
Because loading variables are difficult to control in vivo, a number of investigators have
developed in vitro models to isolate cartilage and study tissue and cellular level effects of
mechanical injury. Mechanical loads applied in vitro range from single compressions of up to
50% strain (Torzilli, 1999; D'Lima, 2001; Ewers, 2001; Kurz, 2001; Patwari, 2003; DiMicco,
12004) to large amplitude cyclic compression at varying frequencies (-0.05 Hz to 0.3 Hz) for up
to 2 hours (Chen, 1999; Chen, 2001; Thibault, 2002; Chen, 2003). Injurious mechanical
compression of cartilage in vitro can damage the extracellular matrix, leading to increased water
content (Chen, 1999; Torzilli, 1999; Loening, 2000; Kurz, 2001), decreased stiffness (Loening,
2000; Kurz, 2001), increased hydraulic permeability (Thibault, 2002), GAG loss to the culture
inedium (Quinn, 1998; Loening, 2000; D'Lima, 2001; Ewers, 2001; Kurz, 2001; Thibault, 2002;
Patwari, 2003; DiMicco, 2004), collagen loss to the medium (Thibault, 2002), and temporary
denaturation of collagen in the tissue (Chen, 1999; Torzilli, 1999; Thibault, 2002; Chen, 2003).
In addition, injurious mechanical compression can lead to cell death by both apoptosis and
necrosis (Quinn, 1998; Torzilli, 1999; Loening, 2000; Chen, 2001; D'Lima, 2001; Chen, 2003),
as well as decreased matrix biosynthesis rates in the remaining viable cells after injury (Kurz,
2001).
Though many studies have focused on the effects of in vitro injurious compression on
cartilage tissue, the resulting modulation of chondrocyte gene transcription has not been fully
elucidated. The objective of this study was to quantify the effects of cartilage injury in vitro on
24 genes central to cartilage maintenance, including genes encoding macromolecules of the
extracellular matrix (ECM), proteases that can cleave ECM proteins and their natural inhibitors,
transcription factors, and cytokines previously shown to affect cartilage metabolism. Using real-
time PCR, we measured levels of mRNA of these molecules at six time points after acute
25
mechanical injury. We observed distinct changes in the pattern and kinetics of expression that
may suggest a role for certain catabolic processes associated with eventual cartilage degradation.
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2.2. MATERIALS AND METHODS
Tissue Harvest. Articular cartilage explant disks were harvested from the femoropatellar
grooves of 1-2 week old calves using previously developed methods (Sah, 1989). In brief, 9 mm
diameter cartilage-bone cylinders were drilled perpendicular to the cartilage surface. These
cylinders were then placed in a microtome holder and the most superficial -200 tm layer was
removed to obtain a level surface. Up to three sequential 1 mm slices were cut from each
cylinder, and 4 disks (1 mm thick, 3 mm diameter) were cored from each slice using a dermal
punch, giving 48 disks in total from each joint. These disks were then equilibrated in culture
medium for 2 days (low glucose DMEM supplemented with 10% fetal bovine serum, 10 mM
YHEPES buffer, 0.1 mM nonessential amino acids, 0.4 mM proline, 20 tg/ml ascorbic acid, 100
U/ml penicillin G, 100 tg/ml streptomycin, and 0.25 [tg/ml amphotericin B) in a 37°C, 5% CO2
environment.
Injurious Compression. After equilibration of the explants, a custom-designed
incubator-housed loading apparatus (Figure 2.1A) (Frank, 2000) was used to injuriously
compress 36 cartilage disks from each joint while the remaining 12 served as free swelling
controls. Cartilage samples to be injured were placed individually into a polysulfone chamber
which allows radially-unconfined compression of the disk by impermeable platens (Figure 2.1 B)
(Kurz, 2001; Patwari, 2003; DiMicco, 2004). The measured thickness of the cartilage disk just
prior to loading was recorded, and the zero-strain position was identified by the point of first
contact between the loading platen and the cartilage surface. The injury protocol consisted of a
single displacement ramp to a final strain of 50% at a velocity of 1 mm/s (strain rate 1.0/s in
displacement control), followed by immediate removal of the displacement at the same rate
(Figure 2.1 C). Application of these strain and strain rate parameters resulted in an average peak
stress of -20 MPa; this loading protocol has been shown previously to produce damage to the
ECM, a significant decrease in cell viability, a decrease in cell biosynthesis by remaining viable
27
cells, and an increase in GAG loss to the medium in similar bovine cartilage explants (Quinn,
1998; Loening, 2000; Kurz, 2001; Patwari, 2003; DiMicco, 2004). After injury, the disks were
placed into fresh culture medium (described above). Groups of 6 cartilage disks were removed
from culture at 1, 2, 4, 6, 12, and 24 hours, flash frozen in liquid nitrogen, and stored at -80°C.
Two groups of 6 free swelling disks were frozen at 4 and 24 hours to serve as controls. Explant
disks in each group of 6 specimens were purposely matched across depth and location along the
joint surface to prevent bias based on location; as a result, each experimental condition
represents an average of specimens within the joint surface.
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Figure 2.1: Loading device and example of compression waveforms. A) An incubator housed
loading apparatus was used to apply injurious compression in displacement control to individual
cartilage disks. The load and displacement were recorded by transducers during loading. B)
Polysulfone chamber used to hold cartilage disks during loading in unconfined compression. C)
Representative data acquired during compression to 50% strain at a strain rate of 1.0/s. Peak
stress reached a maximum value of 20.7 MPa.
RNA Extraction. RNA was extracted from the 6 pooled cartilage disks by first
pulverizing the tissue and then homogenizing in Trizol reagent (Invitrogen, CA) to lyse the cells.
Extracts were then transferred to Phase Gel Tubes (Eppendorf AG, Germany) with 10% v/v
chloroform and spun at 13,000g for 10 min. The clear liquid was removed from above the phase
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gel and RNA was isolated from the sample using the RNeasy Mini Kit (Qiagen, CA). Genomic
DNA was removed by a DNase digestion step (Qiagen, CA) during purification. Absorbance
measurements were read at 260 nm and 280 nm to determine the concentration of RNA extracted
from the tissue and the purity of the extract. The average 260/280 ratio of absorbencies was
1.86+0.12. Reverse transcription of equal quantities of RNA (2.5 tg) from each sample was
performed using the Amplitaq-Gold RT kit (Applied Biosystems, CA).
Real-time PCR. Real-time PCR was performed using the Applied Biosystems 7700
instrument and SYBR Green Master Mix (Applied Biosystems, CA). Primers were designed to
bovine sequences for matrix molecules (collagen II, aggrecan, link protein, fibronectin,
fibromodulin, and collagen I), proteases (MMP-1, MMP-3, MMP-9, MMP-13, ADAMTS-4,
ADAMTS-5), protease inhibitors (TIMP-1, TIMP-2), cytokines (TNF-a, IL-13), housekeeping
(13-actin, GAPDH), transcription factors (c-fos, c-jun, sox 9), and growth factors (IGF-1, IGF-2,
TGF-[) using Primer Express software (Applied Biosystems, CA). Standard curves for
amplification using these primers were generated; all primers demonstrated approximately equal
efficiency, with standard curve slopes -1 indicating a doubling in cDNA quantity each cycle.
Expression levels in injured samples were normalized to those of free swelling control samples
for each gene.
Statistical Analyses. In each experiment, expression levels measured in injured sample
groups were normalized to those of free swelling control groups for each gene; expression data
are presented as the average of three replicate experiments ( SE). Changes in gene expression
levels in the injured samples with respect to free swelling controls at the 4 hour and 24 hour time
points were examined using a non-parametric t-test (Troyanskaya, 2002). The t-test was made
non-parametric by estimating the p-values from permuted data sets (Good, 2000); the t-statistic
was calculated from each of the permuted data sets to create a distribution of possible values.
Using this method, all changes in expression that were 5-fold or greater were found to be
statistically significant. Changes between 2 and 5-fold were also found to be significant with
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three exceptions (c-fos at 4 hours and 24 hours, and c-jun at 24 hours); in certain instances, lower
fold changes were also found to be significant.
Gene Clustering. To distinguish the main expression trends, a k-means clustering
algorithm was applied to the injury time course data (Eisen, 1998; Jain, 1999; Dougherty, 2002;
Fitzgerald, 2004). Each gene was grouped based on the correlation of the time course expression
profile to a set of randomly chosen starting genes. Group profiles were then calculated as the
;average of the expression profiles of the genes in each group. The correlation between each gene
and group profile was calculated and the genes regrouped in an iterative fashion until the
groupings settled. To ensure that an optimal clustering solution for the twenty-four genes was
found, the algorithm was run sufficient times to cover every possible selection of starting genes.
Each set of randomly chosen starting genes produced a deterministic grouping of the genes, with
each gene paired with the highest correlating group profile. The optimal solution was chosen as
the grouping that had the highest overall correlation of genes to group profiles, by averaging over
all the genes (see (Fitzgerald, 2004) for details). The number of groups was varied from three to
six and five groups were chosen to best represent the trends. To determine the distinctiveness of
the main expression trends, the final group profiles were compared using a comparison means
Student's t-test. The Euclidean distance between two group profiles represented the difference of
means, and the average squared distance of the genes within a group to the group profile
represented the variance. The number of genes in each group corresponded to the degrees of
freedom for that group.
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2.3. RESULTS
Gene expression levels in uninjured control cartilage disks. Real-time PCR was used
to determine the gene expression levels of 24 genes of interest in uninjured control cartilage
disks for comparison to mechanically injured disks. Levels of expression of the tested genes
varied over five orders of magnitude, as seen in Figure 2.2, with data normalized to the level of
the lowest expressed gene, ADAMTS-4 (aggrecanase-1). Extracellular matrix molecules as well
as sox 9, a transcription factor promoting expression of matrix molecules in cartilage, showed the
highest levels of expression. Genes typically used as internal controls (e.g., GAPDH, -actin)
showed intermediate levels of expression, while certain cytokines, matrix metalloproteinases,
and transcription factors displayed relatively lower levels of expression. ADAMTS-4 and
ADAMTS-5 (aggrecanase-2) showed the lowest levels of expression of the genes tested.
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Figure 2.2: Free swelling expression levels of 24 genes ranked by relative abundance.
Medium was changed 2 days after harvest and samples were taken 4 and 24 hours after medium
change for gene expression quantification. Levels at the two time points were averaged to give a
single value for each tissue sample. Expression levels were normalized to expression of
ADAMTS-4, the least abundant gene measured. Data are reported as Mean SE for n = 3
replicate experiments using tissue from 3 different joints.
Effects of injurious compression on gene expression. Levels of expression in non-
injured free swelling controls (Figure 2.2) changed selectively in response to injurious
compression. P-values comparing expression levels after injury to control free swelling
expression levels were calculated at the 4 and 24 hour time points and are shown in Table 2.1.
'While expression levels of some genes remained unchanged in response to injury, others
exhibited dramatic differences compared with their free-swelling controls. GAPDH and -actin
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increased in expression -4-fold over free swelling levels after compression (Figure 2.3). Because
these genes showed changing expression levels within the 24 hours after loading, they were not
used as internal controls to normalize the data acquired for the other genes. Rather, all expression
levels were instead normalized by using a fixed quantity of extracted RNA for reverse
transcription as described above in 2.2. MATERIALS AND METHODS. By using a fixed
quantity of RNA from each sample, decreased cell viability in injuriously compressed cartilage
should not affect the levels of expression reported; rather changes in expression should represent
changes within the viable cells remaining in the tissue.
Table 2.1: List of group members generated by k-means clustering with p-values
comparing expression in injured and control cartilage. Gene expression profiles were
iteratively clustered into five groups using k-means clustering. Groups were formed based on
gene to group profile correlation. To compare control and injured cartilage, p-values were
calculated from t-tests performed at the time points 4 hours and 24 hours after injury; bold
represents p-value <0.05, * represents p-value <0.01.
Group 1 Group 2 Group 3 Group 4 Group 5
4hr 24hr 4hr 24hr 4hr 24hr 4hr 24hr 4hr 24hr
MIMP-3 0.01 0.05 c-fos 0.53 0.30 MMP-1 0.07 0.01 IGF-1 0.16 0.08 Collagen II 0.46 0.09
ADAMTS-5 * * c-jun 0.03 0.26 MMP-9 0.83 0.04 IGF-2 0.15 0.49 Aggrecan 0.05 0.02
TGF-f1 * 0.03 MMP-13 0.03 * ADAMTS-4 0.03 0.02 Fibromodulin 0.09 0.72
Collagen I 0.02 0.05 Link Protein 0.12 0.18
TIMP- 1 0.02 0.03 IL- 1 0.09 0.25
TIMP-2 0.69 *
Fibronectin 0.49 0.04
sox 9 * 0.92
GAPDH 0.14 *
1-actin 0.08 0.03
TNF-a 0.91 0.33
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Figure 2.3: Changes in expression level of matrix molecules, -actin, and GAPDH genes
after injurious compression. Values on the y-axis represent fold change from free swelling
levels with a value of 1 indicating similar expression after injury to the level measured in free
swelling conditions. Six cartilage disks were pooled for each time point for each experiment. All
samples were normalized to total RNA at the reverse transcription step. Mean ± SE (n=3).
Extracellular matrix molecules showed no change in expression levels greater than 2-fold
during the 24 hours immediately following compression. Collagen II and aggrecan (Figure 2.3)
as well as fibromodulin and link protein (data not shown) did not change their expression during
the 24 hours immediately following injury. Fibronectin increased -2-fold at the 12 and 24 hour
time points (data not shown).
The most dramatically changing gene in this study was MMP-3, which increased in
expression -250-fold over the free swelling control level following injurious compression
(Figure 2.4). MMP-3 expression began to increase within 2 hours after injury, peaked by 12
hours, and decreased to a -50-fold increase over free swelling level by 24 hours. MMP-13,
however, showed only a -2-fold increase over free swelling level during the 24 hours after injury
(Figure 2.4), and MMP-1 and MMP-9 increased by -6-fold and -4-fold, respectively, over their
free swelling levels (data not shown). Like MMP-3, ADAMTS-5 also showed a dramatic
increase in expression to -40-fold over the free swelling level by 12 hours after injury, and
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remained elevated at -10-fold over free swelling by 24 hours (Figure 2.4). In contrast,
ADAMTS-4, increased only -2-3-fold over free swelling levels and showed little variation with
time in the 24 hours after injury (data not shown). TIMPs, the endogenous tissue inhibitors of
metalloproteinases, were also affected by injurious compression. TIMP-1 increased to -12-fold
over free swelling levels by 12 hours and remained elevated by 24 hours after injury (Figure 2.4).
TIMP-2, which is expressed at an overall higher level than TIMP-1 in free swelling cartilage
(Figure 2.2), was increased by only -2-fold at 12 and 24 hours after injury (data not shown).
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Figure 2.4: Changes in expression level of matrix proteases and tissue inhibitor of matrix
metalloprotease-1 after injurious compression. Values on the y-axis represent fold change
from free swelling levels with a value of I indicating similar expression after injury to the level
measured in free swelling conditions. Six cartilage disks were pooled for each time point for
each experiment. All samples were normalized to total RNA at the reverse transcription step.
Mean + SE (n=3).
The immediate response transcription factors, c-fos and c-jun, responded to injury with a
rapid increase in expression (-120-fold for c-fos and -40-fold for c-jun) within the first hour
after injury (Figure 2.5). By 4 hours, both genes returned to -3-fold over free swelling levels and
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remained moderately elevated for 24 hours. Another transcription factor, sox 9, which promotes
transcription of matrix molecules, did not change expression level significantly during the 24
hours following injurious compression (Figure 2.5). This is consistent with the observed lack of
change in expression levels for the matrix molecules shown in Figure 2.3.
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Figure 2.5: Changes in expression level of transcription factors after injurious
compression. Values on the y-axis represent fold change from free swelling levels with a value
of 1 indicating similar expression after injury to the level measured in free swelling conditions.
Six cartilage disks were pooled for each time point for each experiment. All samples were
normalized to total RNA at reverse transcription step. Mean ± SE (n=3).
Selected growth factors also showed specific changes in expression level in response to
injurious compression. TGF- increased expression in the first 4 hours after injury to a peak
value -7-fold over free swelling levels, remained elevated through 12 hours, and then decreased
to -4-fold over the free swelling value by 24 hours (Figure 2.6). Insulin-like growth factors IGF-
1 and IGF-2 (Figure 2.6) and, similarly, the cytokines IL-I and TNF-a (Figure 2.7) showed
little variation with time (not exceeding 2-fold changes compared to non-injured controls) in the
24 hours immediately following injurious compression.
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Figure 2.6: Changes in expression level of growth factors after injurious compression.
Values on the y-axis represent fold change from free swelling levels with a value of 1 indicating
similar expression after injury to the level measured in free swelling conditions. Six cartilage
disks were pooled for each time point for each experiment. All samples were normalized to total
RNA at reverse transcription step. Mean ± SE (n=3).
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Figure 2.7: Changes in expression level of cytokines after injurious compression. Values on
the y-axis represent fold change from free swelling levels with a value of 1 indicating similar
expression after injury to the level measured in free swelling conditions. Six cartilage disks were
pooled for each time point for each experiment. All samples were normalized to total RNA at
reverse transcription step. Mean + SE (n=3).
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Clustering and statistical analyses of gene expression profiles. Clustering analysis
revealed five groups with distinct temporal expression profiles induced by injury. The group
expression profiles are shown in Figure 2.8, and the corresponding group members are listed in
Table 2.1 along with the associated p-values that were calculated from t-tests performed at the
time points 4 hours and 24 hours after injury to compare control and injured cartilage. In general,
the group expression profiles reflect the main traits of the individual genes within each group
with average correlation coefficients of 0.90, 1.00, 0.89, 0.77 and 0.88 for groups 1-5
respectively. Comparison of means Student's t-tests revealed that the group expression profiles
of Figure 2.8 were distinct. The unique profile of Group 2 was significantly different from
expression profiles of Groups 3, 4, and 5 (p<0.05) and Groups 1 and 3 were also significantly
different (p=0.006). Groups 1 and 2 expression profiles were found to be not significantly
different from each other primarily due to the low number of genes within each of these groups.
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2.4. DISCUSSION
A single injurious compression of cartilage has been shown previously to decrease
extracellular matrix biosynthesis rates, compromise mechanical properties, and reduce
chondrocyte viability (Torzilli, 1999; Loening, 2000; D'Lima, 2001; Kurz, 2001; Patwari, 2003;
DiMicco, 2004). We undertook this study to determine if changes also occur at the level of gene
expression and to determine if the changes are general or specific to certain genes. Analysis of
samples was performed using real-time PCR, which allows the measurement of many genes to
be achieved in a high-throughput manner using a relatively small sample volume. We observed
significant changes in the expression of several catabolic and anabolic genes in response to
mechanical injury, and used k-means clustering (Fitzgerald, 2004) to further analyze gene
expression patterns and co-regulation of specific genes that may result from injury.
Gene group behavior. Clustering resulted in separation of the genes into five groups that
displayed distinct behavior after injury (Figure 2.8, Table 2.1). Group 1 contained MMP-3,
ADAMTS-5, and TGF-f for which large increases in expression level occurred at early times
(within 4 hours) following injury. In addition to directly cleaving matrix molecules, MMP-3 has
been implicated as a member of activation cascades of matrix-degrading enzymes, including
other MMPs. Stimulation of these three genes immediately after injury may represent an attempt
to remodel the damaged matrix by removing some of the matrix molecules or by activating latent
molecules in the matrix. The transcription factors c-fos and c-jun (Group 2) showed an
immediate transient upregulation followed by a rapid decline within 4 hours. c-fos and c-jun are
members of the activating protein-i (AP-1) family of genes that were shown previously to
activate MMPs in a chondrocyte cell line after IL-13 treatment (Vincenti and Brinckerhoff,
2002). This is consistent with the activation of several MMPs in Groups 1 and 3 of this study,
observed at time points following the increased expression of c-fos and c-jun immediately after
injury.
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Figure 2.8: Group expression profiles generated by k-means clustering. The main temporal
gene expression patterns induced by injury of cartilage explants. Group profiles were calculated
by averaging the expression profiles of genes within each group.
Group 3 represents the slowly increasing expression pattern seen for MMPs (other than
MMP-3) and their inhibitors, as well as TNF-c, fibronectin, collagen I, GAPDH, and -actin.
Although expression of sox-9 remained below free swelling levels for all time points tested
(Figure 2.5), this gene clustered into Group 3 because its expression increased from 0.6 to 1.0-
fold of free swelling controls during the 24 hours after injury, as was the case for Group 3
overall. Further investigation is required to determine the extent to which these molecules may
affect cartilage behavior after injury in this system, since the changes in expression were
relatively low.
Group 4 (IGF-1, IGF-2, and ADAMTS-4) and Group 5 (collagen II, aggrecan,
fibromodulin, link protein, and IL-1 P) showed expression patterns that did not vary significantly
with time after injury. Thus, any immediate alterations in ECM biosynthesis that may result from
mechanical injury are unlikely to be related to events at the level of matrix gene transcription
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(Group 5). Any rapid initial repair of matrix immediately after acute mechanical injury is also
not likely to be associated with changes in expression of Group 4 genes.
Comparison to previous studies in vitro and in vivo. The effects of mechanical injury
on the expression of MMP-3 and MMP-13 (Figure 2.4) are similar to trends reported previously
(Patwari, 2003) using Northern analysis of similar cartilage explants subjected to the same injury
protocol of Figure 2.1C. In that study, injury caused a significant increase in MMP-3 expression
over controls (10-fold) but no change in MMP-13 in the first 24 hours. By comparison, when the
data of Figure 2.4 are averaged over the full 24 hour period, MMP-3 appears upregulated 80-fold
while MMP-13 expression changed less than 2-fold. Taken together, these two studies show
similar differential changes in the expression of MMP-3 and MMP-13, obtained using both
Northern and real-time PCR techniques. In vivo studies of OA progression following joint injury
have also reported changes in MMP gene expression levels. Le Graverand et al., using a lapine
ACL transection model of OA, found 2-3 fold increased chondrocyte expression of MMP-3 and
10-30 fold increased expression of MMP-13 (Le Graverand, 2002), which differs in the relative
increases between MMP-3 and MMP-13 seen here and in previous in vitro studies (Patwari,
2003). This difference may be related, in part, to the presence of other tissues in the in vivo
model, such as ligaments, tendons, and synovium, which are not included in the present in vitro
mechanical compression model of injury to cartilage alone.
It is also informative to compare the observed changes in gene expression reported here
to changes in protein levels reported previously in response to mechanical injury of cartilage in
vitro. Immunohistochemical analyses of adult (23 month old) bovine articular cartilage disks
subjected to a rapid ramp displacement to 50% strain and held for 5 minutes revealed an increase
in MMP-1, MMP-3, and MMP-13 as well as a decrease in TIMP-1 and TIMP-2 (Pufe, 2004). A
study applying compressive loading to immature bovine tissue measured increased synthesis and
activity of MMP-2 and MMP-9 after 1-16 hours of loading while no change was measured in
TIMP-1l or TIMP-2 synthesis (Blain, 2001). Porcine cartilage disks from 3-6 month old animals
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subjected to a cutting injury showed an increase in synthesis of MMP-1, MMP-3, and TIMP-1,
while collagen synthesis remained unchanged (Vincent, 2002). Interestingly, our study also
revealed changes in the expression of MMPs and TIMPs, but no change in collagen II
expression. In addition, compression injury was found previously to increase fibronectin protein
synthesis (Chen, 1999), and the compression injury used here caused an increase in fibronectin
gene expression (Table 2.1). Specific differences found in these studies may be due to regulation
at the level of translation as well as to the different injury models used (e.g., cutting vs.
compression).
In vivo studies at the protein level also show certain parallels to the results reported here.
Lohmander et al. analyzed human synovial fluid after ACL or meniscus injury and found
increases in MMP-3 and TIMP-1 protein levels within 1 day after injury that persisted in the
injured joint for 20 years (Lohmander, 1994). Similarly, increased chondrocyte mRNA levels of
MMP-3 and TIMP-1 were found here after cartilage injury and in the lapine ACL transection
model (Le Graverand, 2002). Irie et al. recently found elevated levels of the inflammatory
cytokines IL- 1 and TNF-ca in human joints within 24 hours after ACL injury (Irie, 2003). In the
current study, cartilage injury did not cause an increase in chondrocyte expression of IL-1 or
TNF-ca. While the major source of the increased cytokine, MMP, and TIMP levels seen in the
synovial fluid of injured human joints could be from the synovium or tissues other than cartilage,
it is informative to be able to identify specific changes in chondrocyte gene and protein
expression for comparison.
Comparison to studies of OA tissue. Changes in expression of proteases and cytokines
have been found during the progression of OA. Bau et al. (Bau, 2002) compared chondrocytes
isolated from patients with normal articular cartilage to chondrocytes from patients with early
and late stage OA. MMP-13 and ADAMTS-4 expression increased in late stage OA, while
MMP-3 expression was the highest of the genes tested and was downregulated in OA (Bau,
2002). Murata et al. measured IL-l and IL-l3 gene expression (RT-PCR) and protein levels
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(ELISA) in OA chondrocytes isolated from cartilage obtained during joint arthroplasty (Murata,
2003). They reported a decrease in IL-lac and IL- I transcript in cells from advanced OA tissue
compared to cells from tissue displaying only moderate degeneration. This decrease in
expression was accompanied by a decrease in protein level in advanced OA. In contrast, we
found that the expression of IL- i was not significantly altered by acute compression injury in
vitro (Figure 2.7). Other distinct and important differences were observed in gene expression
'exhibited by OA tissues versus that in explants subjected to acute mechanical injury. For
example, collagen I and collagen II exhibit increased expression levels with the progression of
OA (Gebhard, 2003), while no significant change in the expression of collagen II was observed;
here, following compression injury, collagen I increased expression 2.5-fold by 24 hours and was
found to be statistically significant. It should be emphasized that the focus of the present study is
on immediate changes after injury (within the first 24 hours), while OA develops over a time
span of many years and involves the pathology of the whole joint (Buckwalter and Mankin,
1998). It will be important to expand such in vitro studies to include longer culture periods after
injury. In addition, in vitro models of whole joint injury that involve injured cartilage in the
presence of exogenous cytokines or injured cartilage co-cultured with other injured joint tissues
(Patwari, 2001; Patwari, 2003) may give additional insight into cellular pathways underlying
chondrocyte response to injury.
Comparison to non-injurious loading. Investigators have studied the effects of static
compression on cartilage explants as well as chondrocyte-seeded gels to determine if changes
occur at the levels of gene expression and protein synthesis in these model systems. Cartilage
explants were compressed very slowly to 25% and 50% strain and maintained in compression for
up to 24 hours. This low strain-rate protocol does not alter cell viability (Kim, 1996), in contrast
to the marked increase in cell death and matrix damage typically observed after injurious
loading. These samples were compared to unloaded controls. Results by real-time PCR showed a
transient increase in mRNA levels for aggrecan and collagen II, as well as other matrix proteins,
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followed by a down regulation below control levels by 24 hours (Fitzgerald, 2004). The down
regulation of aggrecan and collagen II expression was shown to be dose dependent by Northern
analysis with 50% compression causing a greater decrease than 25% (Ragan, 1999). Radiolabel
incorporation into proteoglycans and collagen also decreased with increasing static compression
(Ragan, 1999). Transcription of many matrix proteases, including MMP-3, increased with
loading duration 3- to 16-fold by 24 hours of loading (Fitzgerald, 2004). Transcription factors c-
ifos and c-jun were transiently upregulated by 6- to 35-fold after 1 hour of loading (Fitzgerald,
2004). Results similar to those seen for matrix molecule gene expression in cartilage explants
were obtained in a cell-seeded construct. Primary chondrocytes were seeded in collagen I gels
and subjected to static compression of 0%, 25%, or 50% for up to 24 hours (Hunter, 2002).
Results using competitive and real-time PCR showed inhibition of collagen I, collagen II, and
aggrecan mRNA expression. Radiolabel incorporation of proline and sulfate were also inhibited
by the application of static compression (Hunter, 2002). In both of these experimental systems,
changes in mRNA expression level correlated with changes that occurred at the protein level.
Notably, changes seen in response to static compression were markedly different from those
observed in injurious loading scenarios. In the current study, matrix molecules did not change in
expression level as was seen in static compression; also, the magnitude of increased expression
for degradative enzymes and transcription factors were higher in response to injurious
compression compared to non-injurious static compression. Taken together, the response of
chondrocytes to mechanical compression appears to depend on the specific parameters (rate,
amplitude, and duration) of the applied compression.
An unexpected result in the current study was the relatively high level of collagen I
expression in free swelling control tissue (Figure 2.2). Type I collagen molecules can be found in
diseased or damaged articular cartilage; however, it is not an abundant protein in healthy
cartilage. While collagen I expression was, indeed, -60-fold lower than that of collagen II,
mRNA levels were higher than most of the other non-ECM genes studied here. Relatively high
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levels of collagen I expression were previously reported for 6 month old porcine cartilage, and
found to be -3-fold lower than collagen II expression (Fehrenbacher, 2003). The tissue used in
the current study was obtained from newborn bovines, and collagen I expression may vary
widely with age and species. Additionally, cells from the sparse blood vessels present in
newborn cartilage tissue could contribute to the expression of collagen I, as seen in the control
data of Figure 2.2.
One limitation of our study is that samples from different locations within the
femoropatellar groove were pooled; thus, it was not possible to determine if tissue from different
depths and locations along the groove would react differently to injurious compression. Explant
disks in each group of 6 specimens were purposely matched across depth and location along the
joint surface to prevent bias based on location; as a result, gene expression data represent an
average of specimens within the joint surface. Another limitation is the use of newborn tissue.
We and others have previously studied the effects of injury on cell viability and ECM
degradation in the presence and absence of exogenous cytokines using both immature and adult
cartilage from bovine and human joint surfaces and found that certain responses vary with age
(Kurz, 2001; Patwari, 2003; Kurz, 2004). It will be important to extend the present study to
identify any age- or disease-dependence of changes in gene expression caused by mechanical
injury.
In summary, injurious compression caused time dependent changes within 4 to 24 hours
in the expression of specific catabolic and anabolic genes that can regulate matrix remodeling
and turnover, while many extracellular matrix molecules were unaffected. Ongoing studies are
focused on determining whether these changes at the level of gene expression result in changes
in protein levels in the cartilage, and whether the high upregulation of ADAMTS-5 and MMP-3
in response to injurious mechanical compression may be associated with cell-mediated changes
in the proteolytic cleavage of ECM molecules over extended times after injury.
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CHAPTER 3: CO-CULTURE OF INJURED OR UNINJURED
CARTILAGE WITH JOINT CAPSULE TISSUE LEADS TO SPECIFIC
CHANGES IN GENE EXPRESSION LEVELS IN CHONDROCYTES
3.1. INTRODUCTION
Analysis of synovial fluid after joint injury shows increased levels of matrix degrading
enzymes (Lohmander, 1993a), increased markers of matrix turnover (Lohmander, 1993a;
Lohmander, 1993b; Lohmander, 1999; Lohmander, 2003), and elevated levels of inflammatory
cytokines (Irie, 2003) compared to synovial fluid from uninjured controls. The origin of these
factors in the synovial fluid is unknown and could include one or more of cartilage, synovium,
ligament, tendon, and bone. Following joint injury, young adults are at an increased risk for the
development of osteoarthritis (OA) (Davis, 1989; Roos, 1995; Gelber, 2000) irrespective of
surgical intervention to stabilize the joint (Lohmander, 2004; von Porat, 2004). Taken together,
clinical data suggests that the joint environment is altered after injury leading to an increased
likelihood of developing OA.
In vivo animal studies of joint injury have shown changes in both the cartilage and
synovium after transection of the anterior cruciate ligament (ACLT). The ACLT model of joint
injury results in changes analogous to those seen during OA progression including full-thickness
loss of articular cartilage, osteophyte formation, cartilage surface fibrillation, chondrocyte
cloning, hyperplasia of synovial lining, mononuclear cell infiltration, and joint capsule fibrosis
(Brandt, 1991). In addition to gross morphological changes in the joint, ACLT leads to increased
expression of collagen II, aggrecan, MMP-1, MMP-3, MMP-13 and decreased expression of
decorin and fibromodulin in cartilage (Takahashi, 1999; Le Graverand, 2002); synovial cells in
the ACLT joint increase expression of MMP-3 and IL-1 3 (Takahashi, 1999).
In vitro injury models in which cartilage tissue is overloaded result in damage to the
extracellular matrix evidenced by increased water content (Chen, 1999; Torzilli, 1999; Kurz,
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2001), decreased stiffness (Loening, 2000; Kurz, 2001), increased hydraulic permeability
(Thibault, 2002), GAG lost to the culture medium (D'Lima, 2001; Kurz, 2001; Patwari, 2003;
DiMicco, 2004), and temporary denaturation of collagen II (Chen, 1999; Torzilli, 1999; Thibault,
2002). Additionally, cells within the matrix have been shown to decrease biosynthesis rates
(Kurz, 2001) and undergo cell death by necrosis and apoptosis (Torzilli, 1999; Loening, 2000;
Chen, 2001; D'Lima, 2001). In the 24 hours following injurious compression, degradative
enzymes able to cleave extracellular matrix molecules increase gene expression from 5-250-fold
above control expression levels. During the same period after loading, expression of matrix
molecules remains constant at a level equal to that in control uninjured cartilage (described in
detail in CHAPTER 2).
Culturing cartilage in the presence of damaged joint tissues has also been used as an in
vitro model of joint injury. This type of model focuses on the potential effect on cartilage of
factors released from other tissues present in the joint. Co-culture of cartilage with synovial or
joint capsule tissue results in a decrease in biosynthesis rate (Jubb and Fell, 1980; Patwari, 2001)
and loss of staining for proteoglycan and collagen in the cartilage (Fell and Jubb, 1977).
Mechanical injury of cartilage followed by co-culture with joint capsule results in further
reduction in biosynthesis than that measured after injury or co-culture alone (Patwari, 2001).
Synovial or capsular tissue generates soluble proteoglycan degrading activity resulting in
cleavage of aggrecan at the aggrecanase site in the interglobular domain. Treatment with an
inhibitor of IL- 3 and TNF-cc, ACITIC, did not inhibit GAG release caused by co-culture;
however, release was blocked by treatment with EDTA (Vankemmelbeke, 1999). Conditioned
medium from either capsule tissue culture or fibroblast cultures established from explants of
joint capsule caused GAG release from cartilage (Ilic, 2000). Aggrecanase-2 (ADAMTS-5) is
expressed and is active in normal bovine and osteoarthritic human synovium (Vankemmelbeke,
2001). Neither aggrecanase activity nor ADAMTS-5 production by synovial cells was induced
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by IL-lac or retinoic acid (previously shown to upregulate aggrecanase activity in cartilage
(Flannery, 1999)) (Vankemmelbeke, 1999; Vankemmelbeke, 2001).
Previous studies have shown synovium and capsular tissue release cartilage matrix
degrading enzymes as well as cause a general decrease in biosynthesis rates in the chondrocytes.
The effects on chondrocyte gene expression were studied using in vitro models of joint injury.
Models included co-culture of cartilage with joint capsule tissue (including synovium) either
with or without additional mechanical injury of the cartilage. The objectives of this study were to
(1) determine if co-culture of cartilage with joint capsule tissue including synovium can
selectively affect gene expression of components of the extracellular matrix, matrix degrading
enzymes, inhibitors, growth factors, and inflammatory cytokines; (2) determine the effect of
injurious compression on gene expression in co-cultured cartilage; (3) measure specific cleavage
of aggrecan in each of the injury models and compare this to treatment with exogenous IL-1.
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3.2. MATERIALS AND METHODS
Tissue Harvest and Culture. Articular cartilage explant disks were harvested from the
femoropatellar grooves of 1-2 week old calves using previously developed methods (Sah, 1989).
In brief, 9 mm diameter cartilage-bone cylinders were drilled perpendicular to the cartilage
surface. These cylinders were then placed in a microtome holder and the most superficial -200
Mim layer was removed to obtain a level surface. Up to three sequential 1 mm slices were cut
from each cylinder, and 4 disks (1 mm thick, 3 mm diameter) were cored from each slice using a
dermal punch, giving 48 disks in total from each joint. Joint capsule tissue was cut from the
medial side in the joint immediately proximal to the articular cartilage. Full thickness samples
consist of fibrous tissue with a single layer of synovial tissue on the cartilage facing side. Joint
capsule tissue was cut into 36 pieces -5 mm square using a razor. Cartilage disks and joint
capsule samples were then equilibrated separately in culture medium for 2 days (low glucose
DMEM supplemented with 10% fetal bovine serum, 10 mM HEPES buffer, 0.1 mM nonessential
amino acids, 0.4 mM proline, 20 tg/ml ascorbic acid, 100 U/ml penicillin G, 100 [tg/ml
streptomycin, and 0.25 gtg/ml amphotericin B) in a 37°C, 5% CO2 environment. Serum was
replaced with 1% ITS for samples used in Western Analysis.
Injurious Compression, Co-culture, and Exogenous IL-la Treatment. Injurious
compression was performed using a custom-designed incubator-housed loading apparatus
(Frank, 2000) to injuriously compress cartilage disks as described previously (Kurz, 2001;
Patwari, 2003; DiMicco, 2004). The injury protocol consisted of a single unconfined
compression displacement ramp to a final strain of 50% at a velocity of 1 mm/s (strain rate 1.0/s
in displacement control), followed by immediate removal of the displacement at the same rate.
Application of this strain resulted in an average peak stress of -20 MPa and has been shown
previously to result in cell death and tissue matrix damage (Quinn, 1998; Loening, 2000; Kurz,
2001; Patwari, 2003; DiMicco, 2004) when applied to similar bovine cartilage explants. For co-
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culture samples, cartilage tissue was cultured in the same well of a tissue culture plate with a
piece of joint capsule tissue for the duration of the experiment. The two pieces of tissue were not
in contact during culture. Where indicated, cartilage was treated with recombinant human IL- la
(R&D Systems, MN) at 10 ng/ml. IL- la was added at the time of medium change every two
days throughout the duration of the culture. Cartilage maintained in free swelling culture without
Ijoint capsule tissue or exogenous cytokine served as controls for each experiment.
For gene expression analysis, groups of 6 cartilage disks from the experimental treatment
group were removed from culture at 1, 2, 4, 6, 12, and 24 hours, flash frozen in liquid nitrogen,
and stored at -800C. Groups of six free swelling uninjured disks were frozen at 4 and 24 hours to
serve as controls.
For Western analysis, conditioned medium was collected 2, 4, 6, and 8 days after
initiation of treatment (either injurious compression, co-culture, both compression and co-
culture, or IL-l c treatment) at the time of medium change and stored at -200 C. Medium was
collected from free swelling cartilage concurrently to serve as control.
For each experiment, explant disks in each treatment or control group were purposely
matched across depth and location along the joint surface to prevent bias based on location; as a
result, each experimental condition represents an average of specimens within the femoropatellar
groove.
RNA Extraction. RNA was extracted from the 6 pooled cartilage disks by first
pulverizing the tissue and then homogenizing in Trizol reagent (Invitrogen, CA) to lyse the cells.
Extracts were then transferred to Phase Gel Tubes (Eppendorf AG, Germany) with 10% v/v
chloroform and spun at 13,000g for 10 min. The clear liquid was removed from above the phase
gel and RNA was isolated from the sample using the RNeasy Mini Kit (Qiagen, CA). Genomic
DNA was removed by a DNase digestion step (Qiagen, CA) during purification. Absorbance
measurements were read at 260 nm and 280 nm to determine the concentration of RNA extracted
from the tissue and the purity of the extract. The average 260/280 ratio of absorbencies was
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1.91+0.10. Reverse transcription (RT) of equal quantities of RNA (25 ng per tl RT volume)
from each sample was performed using the Amplitaq-Gold RT kit (Applied Biosystems, CA).
Real-time PCR. Real-time PCR was performed using the MJ Research Opticon 2
instrument and SYBR Green Master Mix (Applied Biosystems, CA). Primers were designed for
matrix molecules (collagen II, aggrecan, link protein, fibronectin, fibromodulin, and collagen I),
proteases (MMP-1, MMP-3, MMP-9, MMP-13, ADAMTS-4, ADAMTS-5), protease inhibitors
(TIMP-1, TIMP-2), cytokines (TNF-a, IL-1>3), housekeeping (-actin, GAPDH), transcription
factors (c-fos, c-jun), and growth factor (TGF-f3) using Primer Express software (Applied
Biosystems, CA). Standard curves for amplification using these primers were generated; all
primers demonstrated approximately equal efficiency, with standard curve slopes -1 indicating a
doubling in cDNA quantity each cycle.
Western Analysis for Aggrecan. After addition of protease inhibitors (5mM EDTA,
0.1mM PMSF, and 5mM NEM), culture medium was ethanol precipitated (3 volumes ethanol
with 5mM sodium acetate) overnight at -20°C. Samples were then spun at 13000g for 30min at
4°C. Supernatant was removed and pellet was dried in a Speedvac. The pellet was then dissolved
in digestion buffer (50mM sodium acetate, 50mM Tris, 10mM EDTA, pH 7.6) and treated with
protease-free chondroitinase-ABC, keratanase II, and endo-3-galactosidase to remove GAG
chains from the core protein (Seikagaku, Japan). After digestion, samples were dried in Speedvac
and resuspended in Tris-Gly SDS 2x sample buffer (BioRad, CA) with reducing agent (DTT).
Samples were boiled and then run on 4-15% gradient Tris-HCl gels (BioRad, CA) and
transferred to nitrocellulose membrane at 4°C. Membranes were then blocked and incubated with
primary antibody (one of anti-G1, anti-G3, or anti-NITEGE diluted 1:2000 in 5% non-fat milk)
overnight. Anti-mouse or anti-goat (depending on primary used) secondary antibody incubation
for 1 hour was followed by development using Western Lightning kit (PerkinElmer, MA).
Membranes were imaged for chemiluminescence with Fluorochem (Alpha Innotech, CA).
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Statistical Analyses. In each gene expression experiment, expression levels measured in
treated sample groups (co-culture with joint capsule or injurious compression followed by co-
culture) were normalized to those of free swelling control groups for each gene; expression data
are presented as the average of three replicate experiments (± SE). Changes in gene expression
levels in the experimental treatment samples with respect to free swelling controls at the 4 hour
and 24 hour time points were examined using a non-parametric t-test (Troyanskaya, 2002). The
t-test was made non-parametric by estimating the p-values from permuted data sets (Good,
:2000); the t-statistic was calculated from each of the permuted data sets to create a distribution of
possible values. Using this method, all changes in expression that were 4-fold or greater were
found to be statistically significant with one exception (ADAMTS-5 at 24 hours in injurious
compression followed by co-culture model) with several lower magnitude changes also found to
be significant.
Gene Clustering. To distinguish the main expression trends, a k-means clustering
algorithm (Eisen, 1998; Jain, 1999; Dougherty, 2002; Fitzgerald, 2004) was applied to the
combined data set of time course data for expression following injurious compression, co-culture
with joint capsule, and injurious compression followed by co-culture. Each gene was grouped
based on the correlation of the time course expression profile in the three injury models to a set
of randomly chosen starting genes. Group profiles were then calculated as the average of the
expression profiles of the genes in each group. The correlation between each gene and group
profile was calculated and the genes regrouped in an iterative fashion until the groupings settled.
To ensure that an optimal clustering solution for the twenty-one genes was found, the algorithm
was run sufficient times to cover every possible selection of starting genes. Each set of randomly
chosen starting genes produced a deterministic grouping of the genes, with each gene paired with
the highest correlating group profile. The optimal solution was chosen as the grouping that had
the highest overall correlation of genes to group profiles, by averaging over all the genes (see
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(Fitzgerald, 2004) for details). The number of groups was varied from three to six and five
groups were chosen to best represent the trends.
57
3.3. RESULTS
Co-culture of cartilage with full thickness joint capsule tissue results in specific changes
in gene expression levels of matrix molecules, catabolic enzymes, and cytokines in the
chondrocytes. Changes in expression during co-culture differ in uninjured cartilage tissue and
mechanically injured cartilage.
Typical normalization genes are affected by injury models. Expression of GAPDH
and 3-actin responded to co-culture with joint capsule tissue with increases in expression of 12-
fold and 2-fold respectively (Figure 3.1A). With additional mechanical injury to the cartilage,
increases in expression during co-culture with joint capsule tissue were 7-fold and 4-fold
respectively (Figure 3.1B). Because these molecules responded to co-culture with or without
injurious compression, we did not normalize the expression data of other genes tested to the
expression of either GAPDH or -actin. Instead, all data was normalized only to the total
quantity of RNA in each sample as described in 3.2. MATERIALS AND METHODS.
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Figure 3.1: Changes in expression level of matrix molecules, GAPDH, and -actin during
co-culture of uninjured and injured cartilage with joint capsule tissue. Values on the y-axis
represent fold change from free swelling control levels with a value of 1 indicating similar
expression during co-culture of (A) uninjured cartilage or (B) mechanically injured cartilage to
the level measured in free swelling, non-co-cultured conditions. Six cartilage disks were pooled
for each time point for each experiment. All samples were normalized to total RNA at the
reverse transcription step. Mean + SE (n=3).
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Gene expression of extracellular matrix molecules. Matrix molecules, collagen II and
aggrecan, remained between 65-140% control levels during 24 hours of co-culture with joint
capsule tissue (Figure 3.1A). When cartilage was first subjected to mechanical injury and then
co-cultured with joint capsule, collagen II and aggrecan decreased expression to 40% and 53% of
control levels respectively by 24 hours (Figure 3.1B). Additionally, fibromodulin responded to
co-culture and mechanical injury with a decrease in expression at all time points to 30-60%
control levels while co-culture alone did not significantly affect expression (data not shown).
Link protein increased expression to 130% during the first 4 hours of co-culture, followed by
decrease to 50% by 24 hours; injury followed by co-culture resulted in a non-significant
decreased expression to 70% controls at all time points (data not shown). At all time points
during co-culture of injured or uninjured cartilage, fibronectin was expressed between 60% and
1 5% of expression levels in free-swelling controls (data not shown).
Gene expression of catabolic enzymes and inhibitors. In contrast to the either stable or
decreased expression seen for components of the extracellular matrix, enzymes able to cleave
either collagen II or aggrecan showed selective increases in expression during co-culture with
joint capsule tissue. Stromelysin (MMP-3) showed the largest increase in expression of 16-fold
during 24 hours of co-culture (Figure 3.2A) and a peak 140-fold increase 12 hours after
mechanical injury followed by co-culture with joint capsule (Figure 3.2B). Aggrecanase-2
(ADAMTS-5) increased expression 6-fold over control during co-culture with joint capsule
tissue (Figure 3.2A); mechanical injury of the cartilage followed by co-culture resulted in a peak
in expression 85-fold over control at 12 hours (Figure 3.2B). Aggrecanse-1 (ADAMTS-4)
increased to a peak of 6-fold and 10-fold by 6 hours of co-culture in uninjured and injured
cartilage respectively, returning to baseline by 24 hours in both cases (Figure 3.2). Collagenase-3
(MMP-13) increased to 7-fold above control levels by 6 hours of co-culture, decreasing to 4-fold
over control by 24 hours of co-culture with joint capsule tissue (Figure 3.2A); no response was
seen when cartilage was first mechanically injured (Figure 3.2B). Collagenase (MMP-1) did not
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change expression level during co-culture with joint capsule in either injured or uninjured
cartilage (Figure 3.2). Gelatinase B (MMP-9) decreased to 30% control level in injured cartilage
co-cultured with joint capsule tissue but showed no response to co-culture alone (data not
shown). Tissue inhibitors of metalloproteinase (TIMP) are able to bind to and inactivate MMPs.
TIMP-1 did not respond to co-culture with joint capsule tissue with a change of expression in
either uninjured or injured cartilage (data not shown). TIMP-2 increased expression -2-fold from
4 hours to 24 hours after co-culture in both uninjured or injured cartilage (data not shown).
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Figure 3.2: Changes in expression level of matrix proteases during co-culture of uninjured
and injured cartilage with joint capsule tissue. Values on the y-axis represent fold change
from free swelling control levels with a value of 1 indicating similar expression during co-culture
of (A) uninjured or (B) injured cartilage to the level measured in free swelling, non-co-cultured
conditions. Six cartilage disks were pooled for each time point for each experiment. All samples
were normalized to total RNA at the reverse transcription step. Mean ± SE (n=3).
Gene expression of cytokines, growth factors, and transcription factors.
Inflammatory cytokines, interleukin-lp (IL-1f3) and tumor necrosis factor a (TNF-ca), were
differentially regulated compared to transforming growth factor 13 (TGF-3), during co-culture of
uninjured or mechanically injured cartilage with joint capsule tissue. IL- I increased gradually
during co-culture with joint capsule tissue from 50% to 2-fold above the control level between 1
hour and 24 hours (Figure 3.3A); mechanical injury followed by co-culture with joint capsule
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caused an immediate decrease in expression to 15% control expression which returned to
baseline by 6 hours (Figure 3.3B). TNF-c did not change expression level significantly in either
model at any of the time points measured (Figure 3.3). TGF-P did not respond to co-culture
alone (expressed between 60-150% control at all time points) but showed an increase in
expression of 5-fold between 4 hours and 12 hours after mechanical injury followed by co-
culture with joint capsule tissue, decreasing to 2-fold above controls by 24 hours (Figure 3.3B).
Expression levels of transcription factors, c-fos and c-jun, were increased 2-5-fold during 24
hours of co-culture with joint capsule tissue of uninjured cartilage (Figure 3.4A). One hour after
:mechanical injury and co-culture with joint capsule, expression levels of c-fos and c-jun were
increased to 110-fold and 40-fold of controls respectively decreasing to 1.5-5.5-fold over
controls by 12 and 24 hours of culture (Figure 3.4B).
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Figure 3.3: Changes in expression level of cytokines and TGF-13 during co-culture of
uninjured and injured cartilage with joint capsule tissue. Values on the y-axis represent fold
change from free swelling control levels with a value of 1 indicating similar expression during
co-culture of (A) uninjured or (B) injured cartilage to the level measured in free swelling, non-
co-cultured conditions. Six cartilage disks were pooled for each time point for each experiment.
All samples were normalized to total RNA at the reverse transcription step. Mean + SE (n=3).
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Figure 3.4: Changes in expression level of transcription factors during co-culture of
uninjured and injured cartilage with joint capsule tissue. Values on the y-axis represent fold
change from free swelling control levels with a value of 1 indicating similar expression during
co-culture of (A) uninjured or (B) injured cartilage to the level measured in free swelling, non-
co-cultured conditions. Six cartilage disks were pooled for each time point for each experiment.
All samples were normalized to total RNA at the reverse transcription step. Mean ± SE (n=3).
Aggrecan fragment analysis. To determine if the increase in expression level measured
by real-time PCR of enzymes able to cleave cartilage matrix molecule aggrecan resulted in
cleavage and release of this matrix component to the culture medium, conditioned medium from
cultures was analyzed by Western blotting. Conditioned medium from either uninjured or injured
cartilage cultures in the presence or absence of joint capsule tissue as well as samples containing
joint capsule tissue alone (no cartilage) were immunoblotted with antibodies to globular domains
of aggrecan (anti-G1 and anti-G3) and the N-terminal neoepitope resulting from cleavage by
aggrecanase at amino acid 373 (anti-NITEGE). Medium samples collected on day 4 stained
positively for anti-NITEGE in all conditions that included joint capsule tissue in the culture
(Figure 3.5, lanes 4-8) as well as for cartilage treated with exogenous IL-la. Similar results were
seen with anti-G and anti-G3 antibodies (data not shown). Medium collected on days 2, 6, and 8
showed similar results to that seen on day 4 for all anti-bodies (data not shown). Importantly,
because culture medium from joint capsule tissue alone stained positively for aggrecan cleavage
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products, it is not possible from this analysis to determine if co-culture resulted in increased
damage to the cartilage extracellular matrix through cleavage at this aggrecanase site.
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Figure 3.5: Western blot for aggrecanase fragments in in vitro models of joint injury. Anti-
NITEGE antibody blot of conditioned medium from free-swell control (lane 1), IL- la treated
cartilage (lane 2), mechanically injured cartilage (lane 3), mechanically injured cartilage co-
cultured with joint capsule tissue (lane 4), uninjured cartilage co-cultured with live (lane 5) or
dead (lane 6) joint capsule tissue, live (lane 7) or dead (lane 8) joint capsule tissue cultured
alone. Dead joint capsule tissue was subjected to three cycles of freeze-thaw.
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3.4. DISCUSSION
Co-culture of cartilage tissue explants with joint capsule or synovial tissue has been
shown previously to result in decreased chondrocyte biosynthesis rates and loss of collagen II
and aggrecan from the tissue extracellular matrix (Fell and Jubb, 1977; Jubb and Fell, 1980;
Patwari, 2001). We undertook this study to determine if co-culture with joint capsule tissue
results in changes in gene expression levels in chondrocytes. Real-time PCR analysis was used to
measure expression of 21 molecules involved in both cartilage matrix production and
degradation at six time points from one hour to 24 hours during co-culture with joint capsule
tissue. Gene expression levels were also measured in cartilage first subjected to injurious
mechanical compression and then co-cultured with joint capsule tissue to determine if gene
expression changes in this combinatorial injury model differ from those measured following
injurious compression of cartilage or during co-culture of uncompressed cartilage with joint
capsule tissue. We observed significant changes in expression of several molecules in response
to each of the different injury models of several molecules. Clustering analysis was performed to
summarize the expression levels of genes in the three models of cartilage and joint injury.
Gene expression group behavior. Gene expression profiles of expression levels in the
24 hours following mechanical injurious compression, co-culture with joint capsule tissue, or the
combination of injurious compression followed by co-culture with joint capsule tissue were
clustered to group genes based on their response to all three of these injury models (Figure 3.6,
Table 3.1). Clustering the three data sets together allowed groups to be formed which show
similar expression level responses to the different in vitro models of injury. The behavior of the
individual groups showed levels of response with varied kinetics and magnitudes to each of the
three joint injury models.
Group 1 (Figure 3.6A, Table 3.1) contained matrix molecules aggrecan, collagen II, and
fibromodulin and showed expression levels within 70-120% of control following either injurious
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compression or co-culture with joint capsule tissue. In contrast to what was seen with either
stimulus alone, genes in Group 1 decreased within 1 hour to 70% control and further decreased
to 50% control at 12 and 24 hours following the combination of injurious compression and co-
culture with joint capsule tissue. In contrast, Group 2 (Figure 3.6B, Table 3.1) contained genes
with a variety of functions in chondrocytes (collagen I, link protein, fibronectin, MMP-1, MMP-
9, TIMP-1, TIMP-2. IL- I, TNF-c). On average, the expression levels of the genes in Group 2
increased 3.5-fold in response to injurious compression but remained between 70-120% of
control levels during co-culture with joint capsule in either uninjured or mechanically injured
cartilage.
Group 3 (Figure 3.6C, Table 3.1) which contained matrix proteases (MMP-13 and
ADAMTS-4) and GAPDH (a molecule typically used as a control in gene expression studies)
showed a general increase in expression in response to injurious compression between 1 hour
and 24 hours after loading from 1.5-fold to 3-fold over free swell control. Co-culture of either
uninjured or mechanically injured cartilage resulted in an immediate decrease in expression of
the genes in Group 3 at 1 hour and 2 hours to 40-50% control levels followed by increased
expression of 6-fold and 5-fold above controls of uninjured and injured cartilage respectively.
Gene members of Group 3 showed a larger magnitude response to co-culture with joint capsule
compared to the response seen for injurious compression without co-culture. This may suggest
higher sensitivity of these molecules to factors released from joint capsule tissue compared to the
response to mechanical injurious compression.
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Figure 3.6: Group expression profiles generated by k-means clustering. The main temporal
gene expression patterns in cartilage explants induced by injurious compression, co-culture with
joint capsule tissue, and injurious compression followed by co-culture with joint capsule tissue.
The gene expression data set for clustering consisted of expression levels at six time points each
after mechanical injury (dark blue), during co-culture with joint capsule (light blue) and after
mechanical injury followed by co-culture with joint capsule tissue (red). Expression data was
clustered into five groups. A) Group 1, B) Group 2, C) Group 3, D) Group 4, and E) Group 5
with members listed in Table 3.1. Group profiles were calculated by averaging the expression
profiles of genes within each group.
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Table 3.1: List of group members generated by k-means clustering with p-values
comparing expression in co-cultured and control cartilage. Gene expression profiles in
cartilage following injurious compression and co-culture with joint capsule tissue of uninjured
and injured cartilage were iteratively clustered into five groups using k-means clustering. Groups
were formed based on gene to group profile correlation. To compare control and co-cultured
cartilage, p-values were calculated from non-parametric t-tests performed after 4 hours and 24
hours of co-culture of uninjured or injured cartilage with joint capsule tissue compared to control
expression levels; bold represents p-value <0.05, * represents p-value <0.01.
p-values
Co-culture Co-culture + Injury
Gene 4 hour 24 hour 4 hour 24 hour Group
Aggrecan 0.03 0.06 0.56 0.02 1
Collagen II 0.03 0.03 0.16 0.01 1
]Fibromodulin 0.90 0.15 * * 1
Collagen I 0.04 * 0.50 0.04 2
Fibronectin 0.32 0.95 0.30 0.74 2
I,- I3 0.28 0.01 0.01 0.20 2
,ink Protein 0.01 0.01 0.75 0.36 2
MMP- 1 0.02 0.58 0.03 0.52 2
MP'MP-9 0.02 0.65 0.43 * 2
TIMP-1 0.99 0.68 0.23 0.12 2
TINIP-2 0.03 0.04 0.03 0.03 2
1TNF-a 0.33 0.70 0.45 0.09 2
ADAMTS-4 0.06 0.87 0.28 0.99 3
GAPDH 0.01 0.02 0.02 0.02 3
MMP-13 * 0.39 0.01 0.89 3
ADAMTS-5 0.10 0.06 0.18 0.15 4
P3-actin 0.50 0.38 0.75 0.04 4
4MP-3 0.77 0.01 * 0.05 4
'TGF-13 0.04 0.39 0.02 0.05 4
c-os 0.29 * 0.08 0.01 5
cjun 0.17 0.02 0.09 0.03 5
Molecules in Group 4 showed increases in expression in response to all three of the
injury models (Figure 3.6D, Table 3.1). The four genes in Group 4 varied from lower magnitude
responses (-actin and TGF-P: 4-8-fold increase following injurious compression with or
without co-culture, -2-fold increase during co-culture with joint capsule tissue) to larger
magnitude responses (ADAMTS-5 and MMP-3: 40-250-fold increase following injurious
compression with or without co-culture, 6-16-fold during co-culture with joint capsule tissue). In
contrast to Group 3, which showed larger increases in the two models including co-culture with
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joint capsule, Group 4 showed increases with larger magnitude in the two models including
mechanical injurious compression with all members showing a peak in expression 12 hours after
injurious compression. As a group, these molecules were more sensitive to injurious compression
than co-culture with joint capsule tissue. The matrix proteases, ADAMTS-5 and MMP-3,
showed large increases in expression and may result in degradation of the tissue matrix in these
in vitro injury models. Increased expression of the growth factor TGF- may be indicative of an
effort to repair tissue damage in response to mechanical injury by increasing biosynthesis of
matrix molecules. Alternatively, increased expression of TGF-P may represent an additional
activator of degradative processes as this molecule has been seen previously to activate
aggrecanases (Moulharat, 2004) and collagenase-3 (Moldovan, 1997) in human chondrocytes
and cartilage explants and lead to synovial hyperplasia and proteoglycan loss from cartilage
following intra-articular injection (Elford, 1992).
Transcription factors c-fos and c-jun (Group 5; Figure 3.6E, Table 3.1) showed an
immediate transient upregulation followed by rapid decrease within 4 hours in response to
injurious compression both alone and followed by co-culture with joint capsule tissue. In
uninjured cartilage co-cultured with joint capsule tissue, c-fos and c-jun showed a moderate (2-4-
fold) upregulation at all time points. These transcription factors are members of the activating
protein-i (AP-1) family of genes and have been shown previously to activate MMPs in a
chondrocyte cell line following IL- treatment (Vincenti and Brinckerhoff, 2002).
Medium analysis in co-culture systems. Aggrecan protein fragments were released
from full-thickness joint capsule tissue cultured in the absence of cartilage. Aggrecan production
by joint capsule tissue has been previously reported as a result of cartilaginous differentiation of
the joint capsule which occurs when the hip is subjected to increased mechanical loading during
dislocated hip arthropathy (Yutani, 1999). To determine if cartilage matrix is degraded in an in
vitro co-culture model system, it is therefore necessary to look more specifically at the protein
content of the cartilage tissue itself rather than more generally in the tissue culture medium
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where proteins will be present from all tissues included in the co-culture system. Future studies
will address this issue in the mechanical injurious compression and co-culture models of injury
used here. This finding additionally highlights the need to carefully consider possible sources of
proteins measured in synovial fluid samples obtained from injured or arthritic joints. It must be
considered that the proteins present in the synovial fluid may have been released from a large
:number of tissue sources particularly following a joint injury which disrupts the normal integrity
of one or more of the following: ligaments, tendons, meniscus, articular cartilage surface, or
synovial lining.
Comparison to in vitro co-culture studies. Early studies showed breakdown of the
extracellular matrix of cartilage when co-cultured with minced synovial tissue. Co-culture
resulted in near complete depletion of collagen II and proteoglycan from the cartilage by 14 days
(Fell and Jubb, 1977). Matrix damage was most severe for live cartilage in contact with
synovium with no effect seen of dead synovium. Damage was less severe, though above that
seen in isolated cartilage, when cartilage was at a distance from living synovium. These results
suggest an active role of the cartilage in the co-culture model (larger effect seen for live cartilage
compared to dead cartilage) but do not identify specific catabolic factors that may be responsible
fir the observed matrix degradation. Here, we measured increased expression of specific matrix
proteases in the chondrocytes activated by co-culture with joint capsule tissue (MMP-3, MMP-
13, ADAMTS-4, ADAMTS-5) as well as an additional factor activated by co-culture following
mechanical injury (TGF-3). These factors may play a role in degrading both collagen and
proteoglycan components of the extracellular matrix in these models.
In addition to matrix degradation, co-culture with synovium also results in decreased
biosynthesis rate, measured by 35S04 incorporation, in cartilage when cultured in contact or at a
distance from synovium for 8 days. Tissue was shown to recover biosynthesis rate over 4 days
cultured in isolation following 8 days of co-culture (Jubb and Fell, 1980). Mechanical injurious
compression followed by 6 days of co-culture caused further decrease in incorporation rates of
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35S04 and 3 H-proline compared to 6 days of co-culture without initial compression (Patwari,
2.001). Within the first 24 hours of co-culture with joint capsule tissue, we did not measure a
significant decrease in expression levels of collagen II or aggrecan. It remains possible that
expression of these molecules is reduced during longer incubation periods. Consistent with a
more substantial reduction in biosynthesis rates during co-culture with joint capsule that
followed injurious compression (Patwari, 2001), expression of collagen II and aggrecan were
reduced to -500%, control levels within 24 hours in this joint injury model. Injurious compression
of cartilage alone also did not decrease expression of matrix molecules within 24 hours
(described in detail in CHAPTER 2).
Degradative capacity of synovium. Previous studies report the presence of matrix
proteases able to cleave components of cartilage matrix in synovium tissue as well as by cells
derived from synovium of normal and arthritic joints. Factors that regulate cartilage maintenance
including IL-1, TNF-ac, and TGF-1 additionally regulate expression of proteases in synovium
though differences are seen when compared to the effects on cartilage and chondrocytes.
Both synovium and joint capsule tissue generate a soluble aggrecan degrading activity
when cultured in vitro (Vankemmelbeke, 1999; Ilic, 2000). This activity causes cleavage at the
aggrecanase site in the interglobular domain of aggrecan. Aggrecanase activity is blocked by
EDTA but not by inhibitors of IL-l, TNF-c, or by ACITIC (inhibits trypsin-like serine
proteinases and is able to block cytokine-mediated cartilage breakdown (Bryson, 1998))
(Vankemmelbeke, 1999). Higher aggrecanase cleavage potency was measured in medium from
co-culture of synovium with either live or dead cartilage than that seen from synovium alone
(Vankemmelbeke, 1999). This suggests that in addition to aggrecanase activity released directly
from synovium, there is additional release of a factor(s) retained in the cartilage matrix that
causes increased aggrecan cleavage.
Joint capsule fibroblasts express aggrecanase-1 (ADAMTS-4) and aggrecanase-2
(ADAMTS-5) at the mRNA level (Ilic, 2000). Aggrecanase-2 is present at the protein level in
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human arthritic and bovine normal synovium (Vankemmelbeke, 2001; Yamanishi, 2002). Within
the synovium, aggrecanase-2 is concentrated in the synovial lining and around blood vessels
(mostly pericellular, some matrix staining observed) (Vankemmelbeke, 2001). In synovium from
arthritic joints, aggrecanase-2 is predominantly present in a 53 kDa form compared to normal
synovium in which it is found predominantly in a 70 kDa form (Yamanishi, 2002). Aggrecanase-
2 gene expression and activity are not regulated by IL-la, all-trans-retinoate, TNF-a, or TGF-3
(Vankemmelbeke, 2001; Yamanishi, 2002). Two of the same factors, IL-la and retinoic acid,
increase activity of aggrecanase-2 in cartilage without a concomitant change at the gene
expression level (Flannery, 1999). In contrast to aggrecanase-2, TGF-3 (but not IL- or TNF-a)
increases mRNA and protein expression of aggrecanase-1 in fibroblast-like synoviocytes (FLS)
(Yamanishi, 2002). Similarly, in cartilage from normal and OA joints, TGF-3 also causes an
increase in expression of aggrecanase-1, but not aggrecanase-2 (Moulharat, 2004).
A recent study showed the ability of immune cell microparticles to regulate gene
expression in synovial fibroblasts. Microparticles produced by either activated or apoptotic T
cells and monocytes were shown to increase mRNA expression of MMP-1 (10-70-fold), MMP-3
(8-80-fold), MMP-9 (4-25-fold), MMP-13 (3-30-fold) but not MMP-2, MMP-14, TIMP-1,
TIMP-2, or TIMP-3 in human synovial fibroblasts from normal (obtained at trauma),
osteoarthritic, or rheumatoid arthritic joints (Distler, 2005). MMP activity as well as
inflammatory mediators IL-6 (4-25-fold), IL-8 (8-35-fold), and monocyte chemoattractant
protein (MCP)-l (2-6-fold) and MCP-2 (3-25-fold) were also increased after treatment of
synovial fibroblasts with immune cell microparticles (Distler, 2005). Treatment with a TNF-a
antibody did not reduce MMP induction in synovial fibroblasts caused by microparticles. IL-1
receptor antagonist (IL-IRa) reduced MMP and inflammatory cytokine production by -30%;
similar reduction in MMP and cytokines was seen in IL-IRa treated fibroblasts not exposed to
immune cell microparticles suggesting this decrease is due to blockade of endogenous IL-i
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produced by the synovial fibroblasts rather than a blockade of the effect of the microparticles
(Distler, 2005).
Taken together, these studies outline the ability of a number of factors produced by
synovial cells to act as degradative factors in the joint environment. Further study is required to
determine mechanisms involved in regulation and downstream effects of these factors following
joint injury that may lead to the progression of OA.
Comparison to in vivo injury models. Anterior cruciate ligament transection (ACLT)
results in joint degeneration similar to that seen during the development of osteoarthritis
including full-thickness loss of articular cartilage, osteophyte formation, cartilage surface
fibrillation, chondrocyte cloning, hyperplasia of synovial lining, mononuclear cell infiltration,
joint capsule fibrosis, duplication of the tide mark, and capillary invasion of the calcification
front (Brandt, 1991). In addition to macroscopic changes in the joint indicative of OA, ACLT
results in specific changes in gene expression levels of several molecules in both cartilage and
synovium. Collagenase-3 (MMP-13) is increased -15-30-fold above control 3 weeks after ACLT
decreasing to -7-16-fold above controls by 8 weeks post-ACLT. Other matrix proteases,
collagenase (MMP-1) and stromelysin (MMP-3), were either not changed or increased -2-3-fold
in cartilage from different sites within the joint following ACLT (Le Graverand, 2002). In
another study, MMP-3 expression was increased 9 weeks after ACLT in both the cartilage and
synovium; IL-13 was increased in synovium after ACLT and not detected in cartilage
(Takahashi, 1999). Though the experimental models are quite different, it is interesting to note
that we also measured increased expression in chondrocytes of both MMP-3 and MMP-13 but
not IL- 1 3 during co-culture of cartilage with joint capsule tissue. Together, these studies suggest
that IL- present in joint fluid following injury and during OA progression is not likely produced
by the cartilage but is rather the product of a different tissue in the joint, possibly synovium.
MMI' expression by chondrocytes is increased in both in vivo and in vitro models of injury.
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Three to eight weeks following ACLT, matrix molecules collagen II and aggrecan
increase expression -2-4-fold in cartilage while decorin and fibromodulin expression are
decreased (Le Graverand, 2002). We measured no change or decreased expression of these same
matrix molecules within 24 hours of co-culture of either uninjured or mechanically injured
cartilage with joint capsule tissue.
In our in vitro models of joint injury, the magnitude of the change in expression measured
for aggrecanases, ADAMTS-4 and ADAMTS-5, were quite different with large increases
measured for AI)AMTS-5 expression compared to that measured for ADAMTS-4. Interestingly,
ADAMTS-5 was recently identified as the primary aggrecanase responsible for cartilage
degradation in murine models of OA. A joint instability model showed reduction in pathology,
proteoglycan release, and cleavage at the aggrecanase site in the interglobular domain (IGD) in
ADAMTS-5 deficient mice with no protection seen for ADAMTS-4 deficiency (Glasson, 2005).
Similarly, an inflammatory model of OA showed decreased proteoglycan loss and increased
matrix staining for proteoglycan in ADAMTS-5 deficient mice (Stanton, 2005). These studies
suggest that ADAMTS-5 is primarily responsible for proteoglycan breakdown seen during OA
progression with ADAMTS-4 playing at most a minor role.
Comparison to clinical injury. Long term clinical studies have noted an increased risk
for the development of osteoarthritis following ACL tear (Davis, 1989; Roos, 1995; Gelber,
2000; Lohmander, 2004; von Porat, 2004). The risk for disease is not affected by surgical repair
of the ligament (Lohmander, 2004; von Porat, 2004). In addition, following ACL tear, collagen
II denaturation/degradation occurs in the low weight bearing intercondylar notch similar to the
level of degradation seen in late stage OA (Price, 1999). This suggests collagen II degradation is
an early event following ACL injury and is unlikely to be a direct result of altered mechanical
loading. Taken together, these findings provide evidence that restoration of normal joint loading
is alone insufficient to prevent progressive degradation of cartilage following joint injury.
Motivated by these and similar findings, studies have been undertaken to identify changes that
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occur in the joint environment following injury that initiate or accelerate matrix degradation and
lead to the development of OA. Analysis of synovial fluid after ACL or meniscus tear shows
elevated levels of a variety of factors indicative of both breakdown: including degraded aggrecan
and collagen II, MMP-3, and collagenase, as well as evidence of repair: TIMP-1 and aggrecan
synthesis (Lohmander, 1993a; Lohmander, 1993b; Lohmander, 1994; Lohmander, 1999;
Lohmander, 2003). Additionally, both inflammatory cytokines (IL- I, TNF-c, IL-6, and IL-8)
and suppressors of inflammation (IL-IRa and IL-10) are present at increased levels in the first
week after joint injury (Irie, 2003). These studies highlight the complexity of events following
joint injury and motivate controlled in vitro studies to isolate particular factors and determine the
effect of each in the degradation of cartilage tissue.
We analyzed gene expression response to two in vitro models of joint injury. Our goal
was to isolate the effects on cartilage of two factors: damaged joint capsule / synovial lining
tissue and mechanical overloading. We also sought to understand the interaction between these
two factors by studying the combination model of mechanical injurious compression followed by
co-culture with joint capsule tissue. Using real-time PCR, we measured changes in expression of
extracellular matrix components and matrix proteases and observed a general trend towards
activation of tissue degradation processes in our models. This approach makes possible the
observation of differential effects on chondrocytes caused by mechanical loading and joint
capsule tissue damage.
Our study is limited by inclusion of only two tissue types (joint capsule and cartilage). It
is likely that other tissues and fluids present in the joint have a significant effect on disease
progression following joint injury. Another limitation is the short duration of the study with
measurements made only in the first 24 hours after initiation of each injury model. We sought to
focus first on early time points to measure immediate responses, however, it will be important in
future studies to determine the long term trends in each of these models. A third limitation is the
young age of the tissue used in this study. It is possible that tissue from mature animals will
74
behave differently to the injury models and this should be considered when making comparisons
to other studies.
One caveat stems from our identification of aggrecan fragments released from joint
capsule tissue. It is vital that appropriate outcome measurements be used which correctly
attribute proteins to their source in analyses studying multiple tissues. In addition, aggrecan
measured in synovial fluid, though certainly indicative of general joint damage, may not be a
specific measure of cartilage matrix degradation. Again, the tissue used for this study was from
newborn calves and this finding may depend on tissue age and species.
In summary, our study demonstrates specific changes that occur within the chondrocytes
(luring co-culture with joint capsule tissue. These changes are affected by inclusion of
mechanical injurious compression of the cartilage before co-culture. It is possible to separate the
effects of soluble factors released from joint capsule tissue from effects of mechanical loading
using these in vitro model systems. Future studies are planned to measure cartilage degradation
and protein levels of specific matrix proteases that respond to injury models at the expression
level.
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CHAPTER 4: CHANGES IN CARTILAGE TISSUE COMPOSITION AND
STIFFNESS FOLLOWING IN VITRO MODELS OF JOINT INJURY
4.1. INTRODUCTION
Cartilage tissue provides resistance to tension and compression in weight bearing joints
through its dense extracellular matrix composed predominantly of type II collagen fibrils and
highly negatively charged proteoglycans. The major proteoglycan present in cartilage
extracellular matrix is composed of an aggrecan core protein with 80-100 covalently bound
glycosaminoglycan (GAG) chains. Cartilage matrix is maintained by the chondrocytes present in
the matrix. Chondrocytes respond to mechanical load with changes in the biosynthetic rates of
matrix molecules. Low amplitude dynamic compression (Sah, 1989) and simple shear (Jin, 2001)
increase biosynthetic rates in cartilage explants while injurious compression (Kurz, 2001) and
static compression to 25-50% strain decreases biosynthesis (Ragan, 1999). During the
development of osteoarthritis, cartilage matrix is degraded and is no longer functionally able to
withstand normal levels of loading within the joint. Changes in the molecular structure of the
cartilage matrix, resulting from specific cleavage by matrix degrading enzymes, are likely
responsible for the degradation of the tissue and loss of ability to withstand normal mechanical
loads.
Following clinical injury of the knee, joint synovial fluid contains markers of cartilage
tissue degradation (Lohmander, 1993a; Lohmander, 2003) with specific cleavage of aggrecan
occurring at the aggrecanase site in the interglobular domain (IGD) (Glu373-Ala3 74) (Lohmander,
1 993b). Additionally, cleavage of aggrecan at the aggrecanase site in the IGD is the predominant
catabolic event in cellular mediated aggrecan breakdown in cartilage explants (Sandy, 1991) and
primary bovine chondrocytes (Lark, 1995) following IL-1 treatment. It has been shown that joint
injury leads to increased risk for subsequent development of osteoarthritis (Davis, 1989; Roos,
1995; Gelber, 2000; Lohmander, 2004). In vitro models of joint injury have been developed to
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study some aspects of injury, including mechanical overload and soft tissue tear, on cartilage.
Mechanical overload results in matrix damage, decreased biosynthetic activity of the
chondrocytes, cell death, and compromised mechanical properties (Quinn, 1998; Chen, 1999;
Torzilli, 1999; Loening, 2000; Chen, 2001; D'Lima, 2001; Ewers, 2001; Kurz, 2001; Thibault,
2002; Chen, 2003; Patwari, 2003; DiMicco, 2004; Kurz, 2004). Co-culture of cartilage with
synovium or joint capsule tissue cut from the joint also leads to matrix damage and decreased
biosynthesis activity (Fell and Jubb, 1977; Jubb and Fell, 1980; Vankemmelbeke, 1999; Patwari,
:2001).
Specific aggrecan cleavage products and the enzymes involved in catabolism in in vitro
models of joint injury have not yet been fully elucidated. We undertook this study to determine if
aggrecanase specific cleavage occurs in cartilage tissue explants following mechanical injurious
compression and during co-culture with joint capsule tissue. Secondly, we sought to determine if
matrix damage during co-culture with joint capsule tissue results in a measurable change in the
mechanical properties of cartilage as has been previously measured following mechanical
injurious compression (Kurz, 2001). We hypothesize that a change in mechanical properties at
the tissue level will result in an altered loading environment for the chondrocytes within the
matrix, which will in turn affect synthesis of both matrix molecules and matrix proteases.
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4.2. MATERIALS AND METHODS
Tissue Harvest and Culture. Articular cartilage explant disks were harvested from the
femoropatellar grooves of 1-2 week old calves using previously developed methods (Sah, 1989).
In brief, 9 mm diameter cartilage-bone cylinders were drilled perpendicular to the cartilage
surface. These cylinders were then placed in a microtome holder and the most superficial - 200
tutm layer was removed to obtain a level surface. Up to three sequential 1 mm slices were cut
from each cylinder, and 4 disks (1 mm thick, 3 mm diameter) were cored from each slice using a
dermal punch, giving 48 disks in total from each joint. Joint capsule tissue was cut from the
imedial side proximal to the articular cartilage of the condyle. Full thickness samples consist of
fibrous tissue with a single layer of synovial tissue on the cartilage facing side. Joint capsule
tissue was cut into 36 pieces -5mm square using a razor. Cartilage disks and joint capsule
samples were then equilibrated separately in culture medium for 2 days (low glucose DMEM
supplemented with 10% fetal bovine serum, 10 mM HEPES buffer, 0.1 mM nonessential amino
acids, 0.4 mM proline, 20 yg/ml ascorbic acid, 100 U/ml penicillin G, 100 tg/ml streptomycin,
and 0.25 [g/ml amphotericin B) in a 37°C, 5% CO2 environment.
Injurious Compression and Co-culture with Joint Capsule Tissue. Injurious
compression was performed using a custom-designed incubator-housed loading apparatus
(Frank, 2000) to injuriously compress cartilage disks as described previously (Kurz, 2001;
Patwari, 2003; DiMicco, 2004). The injury protocol consisted of a single unconfined
compression displacement ramp to a final strain of 50% at a velocity of 1 mm/s (strain rate 1.0/s
in displacement control), followed by immediate removal of the displacement at the same rate.
Application of this strain resulted in an average peak stress of -20 MPa and has been shown
previously to result in cell death and tissue matrix damage (Quinn, 1998; Loening, 2000; Kurz,
2001; Patwari, 2003; DiMicco, 2004) when applied to similar bovine cartilage explants. For co-
culture samples, cartilage tissue was cultured in the same well of a tissue culture plate with a
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piece of joint capsule tissue for the duration of the experiment. The two pieces of tissue were not
in direct contact during culture. Cartilage maintained in free swelling culture without joint
capsule tissue served as controls for each experiment. For each experiment, explant disks in each
treatment or control group were purposely matched across depth and location along the joint
surface to prevent bias based on location; as a result, each experimental condition represents an
average of specimens within the femoropatellar groove.
Mechanical Property Measurement. Compressive mechanical properties of the
cartilage were measured 2, 4, 8, and 16 days after mechanical injurious compression, co-culture
with joint capsule tissue, or injurious compression followed by co-culture. Uninjured free
swelling disks cultured in the absence of joint capsule tissue served as experimental controls.
Individual disks were subjected to unconfined uniaxial compression in a polysulfone chamber.
Three sequential compression ramps to 10%, 12.5%, and 15% strain were applied; equilibrium
stress was attained at each step. The equilibrium compressive stiffness was calculated using
linear regression of the equilibrium stress v. stain data at these three points. Dynamic
compressive stiffness was measured during application of sinusoidal compression with amplitude
0.5% strain at five frequencies ranging from 0.01 Hz to 1.0 Hz superimposed on 15% static
compressive offset strain.
Tissue Digestion and GAG Measurement. Following measurement of cartilage tissue
mechanical properties, cartilage disks were digested in 1 ml protease K solution (100 tg/ml in 50
mM Tris-HCl, 1 mM CaC12, pH 8) at 600 C for 18 hours. Glycosaminoglycan (GAG) content of
tissue digests was measured using the dimethylmethylene blue (DMMB) dye-binding assay.
Western Analysis. Aggrecan was extracted from cartilage in 4 M guanidine
hydrochloride/50 mM sodium acetate/5 mM EDTA/15 mM benzamidine/1 Ftg/ml pepstatin A/0.3
M aminohexanoic acid/0.1 mM PMSF by rocking for 48 hours at 40 C. Tissue extract was then
ethanol precipitated (3 volumes ethanol with 5 mM sodium acetate) overnight at -20°C.
Following precipitation, samples were spun at 13000 g for 30min at 4C. Supernatant was
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removed and pellet dried in a Speedvac. The pellet was then dissolved in digestion buffer (50
mM sodium acetate, 50 mM Tris, 10 mM EDTA, pH 7.6) and treated with protease-free
chondroitinase-ABC, keratanase II, and endo-f-galactosidase to remove GAG chains
(Seikagaku, Japan). After digestion, samples were dried and resuspended in Tris-Gly SDS 2x
sample buffer (BioRad, CA) with reducing agent (30 tg/ml DTT). Samples were denatured and
run on 4-15% gradient Tris-HCl gels (BioRad, CA) and then transferred to a nitrocellulose
membrane at 4C. Membranes were blocked and incubated with anti-GI, anti-G3, or anti-
NITEGE primary antibody (1:2000) overnight. Anti-mouse or anti-goat secondary antibody
incubation for 1 hour was followed by development using Western Lightning kit (PerkinElmer,
MA); membranes were imaged for chemiluminescence with Fluorochem (Alpha Innotech, CA).
Statistical Methods. A paired Student's t-test assuming unequal variance was used to
calculate p-values.
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4.3. RESULTS
Models of joint injury result in GAG loss from cartilage tissue. Biochemical
measurement of the glycosaminoglycan (GAG) content of cartilage following mechanical injury,
co-culture with joint capsule tissue, and the combination of mechanical injury followed by co-
culture with joint capsule showed depletion of GAG from the matrix in each of the injury models
by 16 days in culture (Figure 4.1). The GAG content of control free swelling cartilage did not
change significantly over 16 days in culture. Following mechanical injury, a non-significant 5%
decrease in GAG was seen within the first two days after injurious compression. GAG was
significantly decreased after mechanical injury to 90% of control levels by 4 days in culture and
continued to decrease reaching 76% of control by 16 days. Co-culture with joint capsule tissue
also resulted in loss of GAG from cartilage tissue. In contrast to mechanical injury, which caused
an immediate decrease in GAG, during the first eight days of co-culture with joint capsule tissue,
GAG in the cartilage remained within 4% of control levels. By eight days of co-culture, GAG
decreased to 85% of control and further decreased to 76% by 16 days. The combination of
mechanical injury followed by co-culture resulted in the largest magnitude decease in GAG by
16 days in culture to 62% of control levels with little change seen in the first 4 days of culture.
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Figure 4.1: Glycosaminoglycan (GAG) content of cartilage subjected to mechanical
injurious compression and co-culture with joint capsule tissue. Cartilage tissue explants were
subjected to mechanical injurious compression, co-culture with joint capsule tissue, or the
combination of mechanical injurious compression followed by co-culture with joint capsule
tissue. Tissue was digested and GAG content of the digest was measured by DMMB dye binding
assay. * indicates p-value < 0.05 compared to free swell control. Mean + SE (n=4).
Injury models result in specific cleavage of aggrecan at the aggrecanase site in the
IGD. Tissue extracts were analyzed by Western blotting to detect aggrecan protein content of
cartilage explants following mechanical injurious compression, co-culture with joint capsule
tissue, and the combination of injurious compression followed by co-culture with joint capsule
tissue. Antibodies that bind to the globular domains at the N-terminus (anti-G1) and the C-
terminus (anti-G3) showed cleavage of the aggrecan core protein in response to the different
models of joint injury (Figure 4.2). Each of the tissue samples contained predominantly high
molecular weight aggrecan that migrated above the 200 kDa molecular weight standard and had
an intact Gi domain (Figure 4.2A). Aggrecanase cleavage in the interglobular domain (IGD)
results in an N-terminal fragment that runs as a doublet with molecular weight between 60 and
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80 kDa. Injurious compression resulted in accumulation of G1 fragments of aggrecan in the
tissue that are the product of specific cleavage by aggrecanase at this site (Figure 4.2B, lane 2).
Compared to free swell control, injurious compression did not cause additional loss of the G3
domain from the tissue (Figure 4.2C, lane 2), indicative of full-length aggrecan with intact G1
and G3 domains being present following mechanical injury. Co-culture of cartilage with joint
capsule tissue resulted in aggrecanase cleavage products in the tissue (Figure 4.2B, lane 3),
similar to that seen for injurious compression. In contrast to mechanical compression, however,
co-culture with joint capsule tissue resulted in loss of the G3 domain from the tissue (Figure
4.2C, lane 3). The combination of mechanical injurious compression followed by co-incubation
with joint capsule tissue also resulted in aggrecanase cleavage as was seen for both compression
and co-culture alone (Figure 4.2B, lane 4). The combination of compression followed by co-
incubation led to substantial loss of G3 domain from the tissue compared to either compression
or co-culture alone (Figure 4.2C, lane 4).
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Figure 4.2: Western blot for aggrecan core protein in cartilage tissue extract following
mechanical injurious compression and co-culture with joint capsule tissue. Cartilage tissue
extract samples were probed with anti-GI primary antibody (A and B) or anti-G3 antibody (C).
Sample extracts are from free swell control cartilage (lane 1), cartilage following injurious
mechanical compression (lane 2), cartilage co-cultured with joint capsule tissue (lane 3), and
cartilage subjected to injurious compression followed by co-culture with joint capsule (lane 4).
Molecular weigh standards shown to the right in units of kDa.
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Mechanical properties of cartilage are affected by time in culture and injurious
compression. Measurements of equilibrium and dynamic stiffness of cartilage explants were
measured in unconfined compression using a custom designed incubator housed loading
apparatus (Frank, 2000). Equilibrium stiffness decreased by 49% in control samples by sixteen
days in free swelling culture (Figure 4.3A). Injurious compression resulted in a further
significant decrease in cartilage equilibrium stiffness of 32-35% measured two and four days
after injury (Figure 4.3A). Co-culture of cartilage with joint capsule tissue did not affect the
equilibrium stiffness of the cartilage during 16 days of co-culture. Surprisingly, the combination
of injurious compression followed by co-culture with joint capsule tissue also did not decrease
equilibrium stiffness as was observed for injurious compression alone (decreased 18-20%, not
significant). Dynamic stiffness measured at 0.3 Hz showed a continuous decrease with time in
culture in control samples of 36% from day 2 to day 16 (Figure 4.3B). Similar to that seen for
equilibrium stiffness, dynamic stiffness was decreased following injurious compression (13-
38 %). This effect continued through 16 days in culture. Co-culture with joint capsule tissue did
not result in a decrease in cartilage tissue dynamic stiffness. In contrast to equilibrium stiffness,
cartilage subjected to injurious compression followed by co-culture with joint capsule tissue
showed a decrease of 22-30% in dynamic stiffness from two to sixteen days of culture (Figure
4.3B).
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Figure 4.3: Equilibrium and dynamic stiffness of cartilage following injurious compression
and co-culture with joint capsule tissue. Mechanical properties of cartilage explant disks were
measured in unconfined compression. A) Equilibrium stiffness was measured by application of
successive ramp and hold steps in displacement at 10%, 12.5%, and 15% strain. Equilibrium
stiffness reported in MPa. B) Dynamic stiffness was measured by application of 0.5% strain
amplitude sinusoidal compression at 0.3 Hz. Dynamic stiffness reported in MPa. * indicates p-
value < 0.05 compared to free swell control. Mean + SE (n=4).
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4.4. DISCUSSION
Cartilage matrix is composed largely of water, proteoglycan and type II collagen
molecules. The primary proteoglycan present in cartilage consists of an aggrecan core protein
with 80-100 GAG chains attached along the protein backbone. These GAG chains are highly
negatively charged and provide cartilage with the ability to resist compression within the joint.
Through the progression of joint diseases (e.g. osteoarthritis), matrix is broken down and
cartilage looses the ability to respond to loads within the joint. Using in vitro models of joint
injury, we show loss of GAG from cartilage tissue explants following either mechanical injurious
compression or co-culture of cartilage with joint capsule tissue. Additionally, Western blotting of
tissue extracts show cleavage of the aggrecan core protein at the aggrecanase specific site in the
IGD leading to accumulation of aggrecan fragments with the NITEGE amino acid sequence at
the C-terminus resulting from cleavage at the Glu3 73 -Ala374 bond. Finally, the equilibrium and
dynamic stiffness of the tissue was found to decrease with time in culture and following injurious
compression but was not affected by co-culture with joint capsule tissue.
Matrix degradation in in vitro models of joint injury. A number of studies have
previously reported GAG release to the culture medium (Quinn, 1998; Loening, 2000; D'Lima,
2001; Ewers, 2001; Thibault, 2002; Patwari, 2003; DiMicco, 2004) and decreased sulfate
incorporation rate (Quinn, 1998; Chen, 1999; Torzilli, 1999; Kurz, 2001) following injurious
compression. In agreement with previous studies, we measured a decrease in GAG content of
cartilage tissue explants following injurious compression. Previous studies have also reported
GAG loss from the matrix (Fell and Jubb, 1977) and decreased biosynthesis (Jubb and Fell,
1980; Patwari, 2001) during co-culture of cartilage with synovial or joint capsule tissue. By eight
days in co-culture with joint capsule tissue, no significant decrease in the GAG content of the
cartilage was measured. However, by sixteen days in co-culture, there was a significant decrease
in GAG content of the cartilage.
92
Aggrecanase activity in models of joint injury. Both injurious compression and co-
culture with joint capsule tissue caused significant increases in gene expression of aggrecanase- 
and aggrecanase-2 within 24 hours (see CHAPTER 2 and CHAPTER 3 for details). Aggrecanse-
1 (ADAMTS-4) increased 2-fold following injurious compression, 6-fold during co-culture, and
10-fold following injurious compression and co-culture. Aggrecnase-2 (ADAMTS-5) showed
larger magnitude increases of 40-fold following injurious compression, 6-fold during co-culture,
and 85-fold following injurious compression and co-culture. By sixteen days in culture,
aggrecanase cleavage fragments are present in cartilage tissue explants subjected to all three of
these models of joint injury above the level seen in control free swell cartilage. We hypothesize
that this accumulation of aggrecanase specific cleavage fragments results from increased
production of one or both of the aggrecanases by the chondrocytes in response to injurious
compression and co-culture with joint capsule tissue. Additionally, synovial tissue is a source of
aggrecanase-2 protein (Vankemmelbeke, 2001). In the two models that include co-culture with
joint capsule tissue (includes synovial lining), aggrecanase cleavage in the cartilage may also
result from aggrecanase present in the synovium that is released to the medium and able to
diffuse into the cartilage explant.
Comparison to previous measurements of mechanical properties. Previous
measurement of cartilage tissue stiffness in unconfined compression of similar cartilage tissue
explants reported a dynamic stiffness of 10-15 MPa (Buschmann, 1999). This is in agreement
with the stiffness measured in control samples through sixteen days in culture. Korhonen and co-
workers report a Young's Modulus on the order of 1 MPa for adult bovine articular (Korhonen,
2002); this is in agreement with the equilibrium stiffness measured here in unconfined
compression. Injurious compression decreased cartilage stiffness measured immediately
(Loening, 2000) and six hours after loading (Kurz, 2001). We show that this decrease in stiffness
following mechanical injury persists for four days in culture. By eight and sixteen days after
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injury, the stiffness of injured tissue continued to be lower than control tissue samples however
this difference was not statistically significant.
Relationship between GAG content and cartilage stiffness. Glycosaminoglycan
(GAG) molecules in cartilage are highly negatively charged and account for 50% of the tissue
stiffness (Buschmann and Grodzinsky, 1995). In addition to charge repulsion of GAGs during
compression, tissue stiffness depends on steric interactions of proteins in the matrix as well as
higher order organization of molecules in the tissue. Stiffness of cartilage is likely to decrease
immediately after mechanical injurious compression before significant GAG is lost from the
tissue due to large-scale structural damage of the explant, which can be observed
macroscopically. Subsequent GAG loss would lead to further reduction in tissue stiffness in this
model. It is interesting to note that although co-culture of cartilage with joint capsule tissue
results in decreased GAG in the cartilage explant and specific cleavage of aggrecan at the
aggrecanase site, no change in the stiffness of the tissue was measured. Also noteworthy, GAG
content of free swell control tissue did not change with time in culture while stiffness decreased.
It is possible the structure of proteoglycans and association of matrix components within the
tissue are altered during culture both alone and with joint capsule tissue resulting in a lack of
correlation between tissue stiffness and GAG content. Further study will be necessary to fully
determine how a change in molecular content affects tissue level properties. Future studies are
planned to measure the collagen content of the tissue explants and further characterize aggrecan
and collagen fragments. These studies may lead to candidate matrix proteases responsible for
damage seen in each model ofjoint injury.
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CHAPTER 5: SUMMARY AND CONCLUSIONS
Cartilage degeneration that occurs clinically following joint injury presents an interesting
area of research with a multitude of factors that potentially contribute to the observed pathology.
We utilized in vitro models of joint injury to separately study the effects on cartilage of
mechanical overloading and of soluble factors released from damaged joint capsule and
synovium. We also combined these two models by first injuriously compressing the cartilage and
then co-culturing it with joint capsule tissue to elucidate interactions between these two aspects
of joint injury. Analysis was performed by measuring changes in gene expression, protein
abundance, and activity of enzymatic cleavage of matrix molecules. Additionally, we measured
the mechanical properties of the cartilage in each of the models to determine the overall effect on
tissue structure and function.
Chapter 2 describes the effects of a single injurious compression (50% strain, 100%/s
strain rate) on gene expression of matrix molecules, matrix proteases, protease inhibitors,
transcription factors, growth factors, and cytokines. While expression of matrix molecules was
not effected by injurious compression, matrix proteases, ADAMTS-5 and MMP-3, increase to a
peak of 40-fold and 250-fold respectively above control expression levels 12 hours after injury.
Transcription factors, c-fos and c-jun, were also highly regulated by injurious compression
increasing by 120-fold and 40-fold respectively within 1 hour after injury. TIMP-1, an inhibitor
of matrix proteases increased 12-fold over control. Surprisingly, expression of -actin and
GCAPDH were affected by injury making them unsuitable for use as normalization genes in this
study as is often done in gene expression studies. A k-means clustering algorithm was used to
group the gene expression profiles into five groups that showed similar changes in expression
following injury. The relative level of expression in free swelling control samples of each of the
genes is also reported. Expression in control samples varied over five orders of magnitude with
matrix molecules most highly expressed and the aggrecanase enzymes having the lowest
expression levels of the genes tested.
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Chapter 3 extends the analysis of gene expression in cartilage injury models by reporting
changes in expression levels during co-culture of cartilage with joint capsule tissue. This model
aims to investigate the effect on cartilage of damage to other joint tissues including joint capsule,
synovial lining, ligaments, or tendons. The joint capsule tissue used in our studies includes the
synovial lining from the joint as well as the underlying fibrous tissue. Because the capsule tissue
is cut from the joint, it is understood to be damaged with the potential to release soluble factors
-that may have an affect on the cartilage when co-cultured. We compared co-culture of normal,
uncompressed cartilage to cartilage that was first injuriously compressed and then co-cultured
with joint capsule tissue to determine if these two treatments interact. Co-culture with joint
capsule tissue did not affect expression of matrix molecules, similar to what was seen in the
injurious compression model. Interestingly, injurious compression followed by co-culture led to
a 50% decrease in expression of collagen II and aggrecan within 24 hours. Matrix proteases,
MMP-3, MMP-13, ADAMTS-4 and ADAMTS-5, all increased 6-9-fold by six hours of co-
culture with some molecules continuing to increase expression through 24 hours of co-culture
and others returning to baseline. Addition of injurious compression before co-culture with joint
capsule resulted in varying levels of responses by these proteases; MMP-3 and ADAMTS-5 were
highly upregulated to 85-130-fold control, ADAMTS-4 increased 10-fold, and no change was
measured in MMP-13 expression. Again, expression of (3-actin and GAPDH was affected by the
injury models precluding them from use for normalization. Study of the effects on cartilage of
mechanical injurious compression and co-culture with joint capsule separately and then together
allows the response of cartilage to these two different factors to be isolated. As well, the
interaction of mechanical loading and soluble factors present in the joint can be determined.
Finally, analysis of culture medium conditioned with joint capsule tissue contained aggrecan
protein fragments. This finding highlights the need to fully characterize the experimental system
under study in order to correctly identify the origin of any molecules present in the culture
medium containing multiple tissues.
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Chapter 4 describes degradation of the cartilage tissue matrix in each of the injury models
discussed in Chapters 2 and 3. Both injurious compression and co-culture of cartilage with joint
capsule tissue cause a decrease in the GAG content of the cartilage. The combination of injurious
compression followed by co-culture results in a larger magnitude decrease in GAG content when
compared to either treatment alone. Western analysis showed accumulation of aggrecanase
specific cleavage products in cartilage explants following injurious compression, co-culture with
joint capsule, or the combination. Interestingly, while injurious compression either alone or in
combination with co-culture resulted in a decrease in the equilibrium and dynamic stiffness of
the cartilage, co-culture with joint capsule tissue in the absence of mechanical injury did not
affect cartilage stiffness. These results motivate further investigation of the tissue structure of
cartilage over time in culture and in response to these injury models.
In conclusion, we measured specific cellular responses to each of the joint injury models.
Responses varied in magnitude and were time dependent. These studies have identified a subset
of molecules that appear to be involved in the eventual loss of cartilage from the joint surface
following injury. Additionally, we have been able to highlight differences in the effects caused
by mechanical overload of cartilage tissue, damage to other joint tissues, and the combination of
these factors. We found that an altered mechanical or chemical environment results in changes in
gene expression and specific matrix damage with the combination of these events causing more
substantial damage to the tissue than each factor alone.
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APPENDIX A: EXPERIMENTAL PROTOCOLS
A.1. INJURIOUS COMPRESSION USING THE INCUDYN
For experiments involving mechanical injury to cartilage explants, a custom built
incubator housed loading apparatus (IncuDyn; Frank, 2000) was used. This machine allows
application of distance controlled or load controlled waveforms in real time as programmed by
the user. For the experiments described in this Thesis, the IncuDyn was used in displacement
control to apply 50% strain at a strain rate of 100%/s to cartilage explants cut to 3 mm diameter,
1 mm thick disks.
For loading, cartilage explants were placed in a single-well polysulfone chamber
(designed and machined at MIT) and mechanically compressed individually as described in
Table A. 1. This loading protocol includes one step of machine set-up (Find bottom of chamber)
that calibrates the machine to set the zero displacement location to be equal to the bottom of the
well in the loading chamber. Because the chamber has an indentation of 130 tm below the
surface reached by the platen when lowered, an offset of this magnitude is included when setting
the zero displacement location. After setting the zero displacement, the platen is raised to 1.35
mm to allow space for the cartilage explant to be inserted into the machine without initial
compression. After calibration, a single cartilage explant (3 mm diameter, 1 mm thick) is placed
in the polysulfone loading chamber and the chamber placed in the IncuDyn. A compression ramp
is then applied, lowering the platen until the force exceeds 50 g (indicating the platen is now in
contact with the explant). The displacement of the platen is then stopped and the location is
recorded as the sample thickness. The parameter DispRelative is then set to zero and serves as an
input to the compression signal applied during injurious compression. After measuring and
recording the sample thickness, a ramp to 50% compression is applied, mechanically injuring the
explant. After loading, the platen is raised to 1.35mm to allow the loading chamber to be
removed from the IncuDyn and the next sample to be inserted.
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'Table A.1: Injurious compression protocol (File: C:\Users\Jenny\Injury.pro). The IncuDyn
machine in the Grodzinsky Lab at MIT was used to mechanically injure cartilage explants for
gene expression and matrix degradation analyses.
Find bottom of Compression ramp: -2 mm in 60 sec, 10 samples/sec
chamber Terminate when force reaches -500 g
Set signal: displacement = offset 130 [xm
Find top of plug Offset load = 0 g
Compression ramp: -2 mm in 60 sec, 10 samples/sec
Terminate when force reaches -50 g
Set parameter: thickness = displacement
Offset DispRelative = 0 m
Injure Compression arbitrary (C:\Users\spike.arb): amplitude = -55%,
in I sec, end 1.5 sec, 100 samples/sec
Goto 1.35 mm, velocity 500 [tm/s
One important consideration when choosing parameters for a loading protocol is an
inconsistency between the programmed strain amplitude and the strain amplitude recorded
during loading of the explant. When programmed to apply 50% strain, the IncuDyn consistently
records a strain of 45%; when programmed to apply 55% strain, the recorded strain is 50%.
Previous studies performed in the lab using mechanical injury of cartilage report peak stress -20-
22 MPa with gross damage to the tissue in the form of an elliptical sample shape or cracks
visible immediately after loading. With the strain set to 50%, gross damage does not occur as
often and peak stress is typically -14-18 MPa. To more closely match previous experiments, the
strain setting was increased to 55% for studies reported in CHAPTER 4. This level of strain
more often resulted in visible tissue damage and a strain -20 MPa. For experiments reported in
CHAPTER 2 and CHAPTER 3, strain was set to 50%.
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A.2. JOINT CAPSULE TISSUE HARVEST AND CULTURE
For experiments involving co-culture of cartilage with joint capsule tissue, capsular tissue
was harvested at the time of cartilage explant harvest. Co-cultured cartilage and joint capsule
tissues were always harvested from the same joint. Full thickness capsular tissue was first cut
from the joint before drilling cartilage-bone cylinders and was placed in a petri dish in medium
with the synovial lining facing down. This tissue was then cut into samples for use in co-culture
experiments inside the tissue culture hood. Procedures are described below in more detail.
After securing the joint in the vice grip (following removal of femoral head), the
outermost layer of tissue (-100 ptm) was removed in multiple stages with blade changes with the
goal of uncovering a sterile layer of tissue. The joint surface was then washed with sterile PBS.
With a new blade, the patellar tendon was cut -5 cm below the patella. This cut was then
extended laterally to produce an opening across the entire front of the joint. The cut was full
thickness and extended into the joint space at approximately the position of the meniscus. Using
a scalpel blade, a cut was then made full thickness through the capsule tissue medial to the
patellar tendon extending upward to the transition between capsular tissue and muscle. A cut was
then made medial and then downward along the transition between capsule (white) and muscle
(pink) to result in a piece of capsular tissue removed from the joint. Cutting this piece of tissue
should expose the medial condyle and include the layer of synovial tissue in contact with the
cartilage in the native joint. This piece of tissue was placed synovium side down in a petri dish
containing medium. This was then repeated on the lateral side. Care was taken to include the
synovial tissue on samples from both the medial and lateral side.
In the culture hood, tissue was cut with a scalpel into pieces -4-5 mm across. For
experiments described in CHAPTER 3, full thickness joint capsule tissue including the fibrous,
collagen rich tissue as well as the loose connective tissue and synovium was used for co-culture
experiments (-5 mm thick). This tissue quickly dulls razor blades when cutting and requires
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-1.5-2 ml of medium, changed every two days, for culture. Due to conversations with Ernst
IHunziker (University of Bern, Switzerland) discussing samples fixed and sent to his laboratory
for analysis by histology (Figure A.1), it was decided to use only the loose connective tissue
separated from the fibrous tissue. It is thought that this tissue included the majority of reactive
cells/factors seen to have an effect in co-culture experiments. Tissue pieces still included the
synovial layer. In order to remain as consistent as possible with previous experiments, this tissue
was cut into pieces -4-5 mm across (-0.5 mm thick) with the thinking that this would include the
same volume of synovial cells. These samples required less culture medium; 0.75 ml for two
days was sufficient.
Figure A.1: Histology of joint capsule tissue used in co-culture experiments. Full thickness
joint capsule tissue was harvested from the medial side of the patellar tendon. Tissue was fixed
in 10% formalin and prepared for histology in the Hunziker Lab in Bern, Switzerland. For
experiments in CHAPTER 3, full thickness tissue was used in co-culture experiments; for
experiments in CHAPTER 4, only the synovial lining and loose connective tissue (appearing on
the right side of the above image) was used for co-culture.
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A.3. REAL-TIME PCR
A.3.1. SUPPLIES
Low profile multiplate 96, white
8-strip ultra clear caps
12-strip 0.2ml thin-wall tubes
2-20[tl LTS multipipette, 12 channels
Precision pipette tips, sterilized
SYBR Green PCR master mix
Primers
RNase, DNase free water
MLL-9651
TCS-0803
TBS-1221
RT-L10F
4309155
supply sequence
10977-015
MJ Research
MJ Research
MJ Research
Rainin
Rainin
Applied Biosystems
MWG Biotech
Gibco
A.3.2. SUPPLIERS
Gibco
Grand Island, NY
('716) 774-6700
www.invitrogen.com
MJ Research Inc
Watertown, MA
(888) 735-8437
salesmjr.com
Applied Biosystems
Foster City, CA
(800) 638-5800
vwww.appliedbiosystems.com
Rainin
Woburn, MA
(800) 472-4646
pipets@rainin.com
MWG Biotech
High Point, NC 27265
(877) 694-2832
info(¢mwgbiotech.com
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A.3.3. PRIMERS
* Designed using Applied Biosystems Primer Express software available on the Applied
Biosystems real-time PCR machine
* Ordered from MWG Biotech: scale 0.01, lyophilized
* Water added (DNase, RNase free) to concentration of 100 pmol/tl as indicated in the
package insert.
* Stock diluted 10x for use in real-time PCR reactions:
20 tl forward primer
20 tl reverse primer
160 tl water
A.3.4. PROCEDURE
1. Wipe lab bench, pipettes, pipette tip boxes with 70% Ethanol to clean.
2. Fill an ice bucket to top with ice.
3. Place two black plate holder trays in the ice (if you can find them). One will be used to
hold the plate, the other will hold the strips of tubes for mixing reagents.
4. Place one strip of 8 tubes vertically in the plate holder, one strip of 11 horizontally.
5. Pipette 90 tl master mix into each of the 11 horizontal tubes.
6. Add 13.5 1I of one of the 1 1 primers to be tested into each tube across the row mixing
with the pipette.
7. Pipette 84 tl water into each of the 8 vertical tubes.
8. Add 18 Al of one of the 8 samples (cDNA) to be tested into each tube down the column
mixing with the pipette.
9. Open a new box of Rainin multipet pipette tips.
10. Place a new 96 well multiplate into the second plate holder.
11. Set the multipet to 8.5 Vtl.
12. Get one full column of tips (8) from the box (will be left with 8 rows of 11 tips).
13. Mix the column of 8 samples with the pipette and pipette 8.5 dl of solution into each
column in the plate.
14. Remove tips from pipette.
15. Set the multipet to 11.5 Vl.
16. Get row of tips ( 1) from the box.
17. Mix row of 1 1 master mix/primer with the pipette and pipette 1 1.5 tl of solution into
each row in the plate, mix when adding to the plate with the cDNA and water, do not
fully plunge pipette - will lead to bubbles in samples, change tips between each row.
18. Collect 20 tl total volume from leftover master mix/primer solutions and pipette into the
'no template control' well.
19. Use black cap tool to cover each well with a clear cap (even empty wells must be
covered). Do not touch tops of caps as optical reading is taken through the cap and
fingerprints may interfere.
20. Spin plate in plate spinner in the BioMicro Center for -1 min.
21. Use real-time PCR machine to analyze samples.
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A.3.5. ANALYZING THE DATA
1. Subtract baseline (average florescence in cycles 1-10) from all samples.
2. Choose threshold: should be in the linear range of increasing signal, if possible, use the
same threshold for all genes (MUST use the same threshold within one gene for all
samples).
3. Export C-r for each well into an Excel spreadsheet.
4. Calculate relative quantity of cDNA in each sample as Quantity=2(4°0 CT).
5. To compare relative expression levels in two samples, use the ratio of Quantityl to
Quantity2. This gives the fold change in expression between the two samples
A.3.6. VOLUME CALCULATIONS
,ell:
master mix
mixed forward/reverse primer
RNase, DNase free water
cDNA
1
]
x9
x 12
Total needed:
901l master
13.5p1 mixed
84,tl water
18tl cDNA
mix
primer
This set-up allows testing of 8
template control (NTC)
experimental conditions for 11 different genes with room for a no
11 different genes
No template control
107
Per 
1.5/1
7jl
1.5yl
A.3.7. PLATE SET-UP
e,Q
U)
.D
c0a)
ao
A.3.8. THERMOCYCLE PROTOCOL
Temp (C) Time (min)
50
95
94
60
2
10
1
Repeat 40 cycles
Reading is taken at the end of the minute at 600 C.
PCR is followed by a melting curve: measure florescence at each degree between 60°C and
90°C. This allows verification that primers are producing a single product with the expected
melting temperature.
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A.4. AGGRECAN EXTRACTION, MEDIUM PREPARATION, AND WESTERN
BLOTTING
A.4.1. GUANIDINE HCL EXTRACTION
4 M guanidine
0.3 M amino-caproic acid (Sigma A2504 "AHA")
50 mM Na acetate
15 mM benzamidine
5 mM EDTA
5 mM iodoacetic acid (Sigma 12512 "IAA") can substitute NEM
0.1 mM AEBSF (Sigma A9456) can substitute PMSF
1 jtg/ml pepstatin A, pH 6.5 (store as 100x in methanol) (Sigma P4265)
Chop cartilage disks (1-2) at room temp or pulverize cartilage disks (>3) in liquid N2, add
500-1000 [tl GuHCl solution with protease inhibitors. Incubate 48 hours, 4°C, with
agitation.
A.4.2. GAG MEASUREMENT
* Use DMMB assay; need to get 100 jig GAG per sample
A.4.3. ETHANOL PRECIPITATION (ETHANOL PRECIPITATE EITHER CULTURE
MEDIUM OR TISSUE EXTRACT FROM ABOVE)
5 mM Na acetate in absolute ethanol
If ethanol precipitating medium, add 5 mM EDTA, 0.1 mM PMSF, and 5 mM NEM from
concentrated stock solutions to medium before EthOH precipitating.
* Add 3 volume of ethanol (with Na acetate) to medium or tissue extract and store at -20°C
overnight
* Pellet the precipitate:
o Centrifuge at 13,000 rpm for 30 min.
o Discard supernatant. Cover tubes with parafilm, poke hole in top so gas can
escape, freeze in liquid N2 or -80C freezer, dry in Speedvac 30 min or lyophilize.
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A.4.4. GAG DIGESTION
* Resuspend 100 pg GAG lyophilized sample in 100 pl Chase Buffer:
0.05 M Tris HCl (or Tris Base - must adjust pH)
0.05 M Na acetate
0.01 M EDTA
pH 7.6
[note: for a 20 ml solution: 60 mg Tris base (MW 121.1), 41 mg Na acetate (MW 82.03),
37.2 mg E DTA (MW 372.2)]
* Assay GAG content again after ethanol precipitate is resuspended in buffer.
* Digest with protease-free chondroitinase ABC (25 mU/100 fig GAG) (Warner) for 3
hours in a water bath of 37°C.
* Add keratanase II (0.5 mU/100 Cpg GAG) and endobetagalactosidase (0.5 mU/100 pig
GAG) (Seikagaku #100455, #100812, respectively... 1 mU/pIl when rehydrated)
[note: Dilute 2.5 pl into 20 ll water - 0.5 mU/5pl] and digest at 370 C for an additional 2
hours.
A.4.5. RUN THE WESTERN
* Take 10-20% of each sample and lyophilize or dry in Speedvac.
* Make 400 pl sample buffer
0.012 g dithiothreitol (DTT, Cleland's reagent, Sigma D0632) [DTT stock: 154.5 mg in 1
ml 10 mM sodium acetate + 250 pl1 DI water for final concentration: 30 mg/ml] (Note:
this is for a reducing gel, for non-reducing, leave out DTT, replace with water)
100 pl 12 M urea [7.2 g urea (MW 60.06) into 10 ml water]
200 pl1 Tris-Gly SDS 2x sample buffer (BioRad Laemmli #161-0737)
* Resuspend each sample in 15 pl sample buffer
* Make standards; mix 4 pl + 11 pl sample buffer - can use either or both of the following
Rainbow Visible Standard 220kDa to 30kDa; Amersham RPN 756
Biotinylated protein ladder; Cell Signaling #7727
* Denature proteins (samples and standards): boil 5 minutes at 100°C
* Use 4-15% (gradient) Tris-HCl gel (BioRad Ready Gel, 10 wells, 30 pl, #161-1104)
* Assemble gel:
o Cut off the bottom of the thin plastic cover on the gel cassette. Make sure the
rubber gasket has notch facing out. Slide the cassette over the thick plastic plate
(with the wells facing upward and away from the thick plastic). Tighten screws.
Snap into main chamber with wells pointed inward.
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Load samples on gel:
o Place the inner chamber inside the outer chamber (the gel should be run with the
entire apparatus in an ice bath).
o Fill the inner chamber with enough running buffer to cover the wells but not spill
over, check to see if the inner chamber is leaking, tighten screws if necessary.
Running buffer:
50 mM Tris base (6 g/L; MW121.1)
384 mM glycine (28.8 g/L; MW75.02)
2 g/L SDS
*store in fridge
o Carefully remove the comb.
o Load samples. Don't introduce air bubbles.
o Fill outer chamber with running buffer above the level of the wells (this will
minimize leakage from the inner chamber)
o Connect red-red, black-black.
o Start at 100 V. Check to make sure the electrodes are connected properly (or the
bands may migrate upward and out of the gel.). After a few minutes, the bands
should be migrating down.
o Run at 130-150V for 40-60 min in a cold room or an ice bath.
(note: Higher voltage may lead to slanted bands)
A.4.6. TRANSFER
* Prepare transfer buffer
25 mM Tris base (3.03 g/L; MW 121.1)
192 mM glycine (14.4 g/L; MW 75.02)
20% methanol
*store at 4°C
* Remove gel:
o Break cassette, cut off wells
* Create blotting sandwich:
o Immerse all components in transfer buffer to remove all air bubbles. Leave in
fluid for 5 minutes or roll all air bubbles out by applying pressure to the paper
and sponge.
o Loading order:
* Black side down
* Sponge
* Blotting Paper (Sigma P4431, 7x10cm)
* Gel
* Nitrocellulose Membrane (cut to size before this step)
* Blotting Paper
* Sponge
* Close cassette
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* Load Transfer Apparatus:
o Place black side to the black side of the inner chamber. Place ice block in
chamber. Fill chamber until the membrane and gel are covered.
o Add magnetic stirrer to keep fluid moving and cooled.
* Transfer at 70V for 2 hr in cold room with ice block in buffer to keep solution cool.
A.4.7. BLOCKING
* Prepare Tris-buffered saline (TBS) and TBS with Tween 20 (TBS-T)
20 mM Tris base (2.42 g/L; MW 121.1)
0.137 M NaCl (8 g/L)
pH 7.6 (will need to add lots of HC1)
Add 0.1% Tween20 (1 mL/L) for TBS-T
*store in fridge
* Blocking solution:
TBS-T with 1% dry nonfat milk (0.2 g into 20 ml TBS-T)
* Block membrane in blocking solution for 5-10 min., room temperature on shaker.
A.4.8. PRIMARY ANTIBODY PROBE
* Prepare TBS-T with 5% dry nonfat milk (1.0 g in 20 ml TBS-T)
* Incubate overnight with primary antibody at 4°C on a shaker
(note: exact dilution is dependent on each antibody, -1:1000-3000)
anti-G1 from J. Sandy: 1:2000
anti-G3 from J. Sandy: 1:2000
anti-NITEGE from Wyeth: 1:2000
anti-ADAMTS-4 (6hAgglP3/30) from Wyeth: 1:2000
anti-ADAMTS-5 from Wyeth (2 different Ab - lhAgg2P3/3 better for use in non-
reducing conditions and 3hAgg2P3/34 which works equally well in reducing and
non-reducing but not as good as lh in non-red): 1:2000 for either
A.4.9. SECONDARY ANTIBODY PROBE
* Wash in 15-20 ml TBS-T for 5 min. (x2)
* Incubate in TBS-T with 5% milk plus secondary antibody for 1 hour at room temperature
on shaker
Dilution: 1:2000 (10gl:20ml) for HRP-linked anti-rabbit IgG (for J. Sandy
primaries); Cell signaling #7074 or HRP-linked anti-mouse IgG (for Wyeth
primaries); Cell Signaling #7076
Include anti-biotin HRP-linked Ab (Cell Signaling #7075) if using biotinylated
standards (101l:20ml)
Note: Longer incubations than 1 hour can lead to non-specific binding
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A.4.10.WASH
Wash in TBS-T for 10 min. (x3)
Note 1: On the last wash, get ready to develop the membrane. If you wait too long, the
antibodies will wash off.
Note 2: If you need to keep the membrane in fluid, store in TBS (no Tween).
A.4.11.DEVELOP USING WESTERN LIGHTNING (PERKINELMER NEL104)
* Get the following equipment ready:
Aluminum foil
15 ml conical tube
Small plastic box
P1000 pipette and tips
Forceps
Western Lightning kit
Gloves
Nitrocellulose membrane
* Pipette 1 ml of each of the two Western Lightning solutions into 15 ml tube. Wear
gloves, the chemicals are toxic. Vortex to mix.
* Pour solutions into small plastic box.
* Place membrane face down in box on top of solution.
* Close box and cover with foil.
* Incubate 1 min.
* Place the membrane face up in imager (Dedon lab - 2 nd floor 500 Tech Square - Alpha
Innotech Flourochem 8900)
* User name: JOHN K; password: BASS
* Click ACQUIRE
* With door open, arrange membrane in center of field, adjust camera so membrane fills
window; close door.
* Filter in position 1 (for chemiluminescence)
* Click MOVIE SETUP; then LOAD SETUP.
· Load G1 movie, or 1 Omin movie (for NITEGE or enzyme gels).
GI: total frames=5, lengths=lOs, 20s, 30s, lm, m.
10min: total frames=7; lengths=l0s, 20s, 30s, lm, 2m, 3m, 3m.
sensitivity/resolution: medium/medium
stack frames checked
noise reduction checked
· Click GO to begin imaging
· SAVE movie stack (will save image as it appears after each additional stacked frame as a
separate file).
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A.5. MECHANICAL PROPERTY TESTING
Objective: Measure mechanical properties of cartilage tissue samples using the IncuDyn.
Measurements made in compression and shear, static and dynamic. Initiated to determine if co-
culture with joint capsule tissue results in a measurable change in the mechanical properties of
either injured or uninjured cartilage. Injury has been shown to decrease the stiffness of cartilage
(Kurz, 2001).
A.5.1. USING THE INCUDYN
SETUP THE LOADING MACHINE:
1. Attach lid of loading chamber to the rod on the top of the machine with three screws.
2. If loading in shear, attach bottom of chamber to the floor of the loading machine. The
stage rotates during shear loading and so needs to be attached to the chamber to apply a
load.
3. Move the lid down to be in contact with the bottom of the chamber (load to -1 00g to
-2kg). This may require moving the load cell up or down to be in the dynamic range of
the instrument.
4. Once the lid is in contact with the bottom chamber, move the load cell to be near the
lower end of its dynamic range (since this is the lowest position the lid will reach during
loading, you will maximize the measurable range).
COMPRESSION:
Test one plug at a time (3 mm diameter, 1 mm thick)
Use clear polycarbonate chamber.
1. Load protocol file (Jenny/mech prop.dyn).
2. Open output file.
3. Find bottom of chamber.
4. Raise lid.
5. Place plug in center of chamber, cover with 100 tl medium.
6. Lower lid to engage load cell but not load the plug.
7. Double click "Find top of plug" step in protocol. This lowers the lid until the cartilage is
in contact with the lid and sets the sample thickness to this height.
8. Double click "Mechanical testing starts here" step. The program will run through the
entire loading protocol to test static and dynamic mechanical properties in compression.
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SSHEAR:
Test four plugs at a time (each plug: 3 mm diameter, 1 mm thick)
1. Load protocol file (Jenny/shear mech prop.dyn).
2. Open output file.
3. Find bottom of chamber.
4. Raise lid.
5. Place each plug in center of chamber, cover with 1001tl medium.
6. Lower lid to engage load cell but not load the plug.
7. Double click "Find top of plug" step in protocol. This lowers the lid until the cartilage is
in contact with the lid and sets the sample thickness to this height.
8. Double click "Mechanical testing starts here" step. The program will run through the
entire loading protocol to test static and dynamic mechanical properties in shear.
A.5.2. TESTING PROTOCOL
COMPRESSION:
1. -10% ramp compression in 60 seconds, hold for 240 seconds (300 sec total time).
2. -2.5% ramp compression to -12.5% in 20 seconds, hold 160 seconds.
3. -2.5% ramp compression to -15% in 20 seconds, hold for 160 seconds.
4. Sine wave amplitude 0.5% at frequencies: 0.01, 0.03, 0.1, 0.3, 1.0 Hz.
Total testing time: -25 min to setup and run protocol.
SIHEAR:
1. -15% ramp compression in 60 seconds, hold for 240 seconds.
:2. 1% ramp shear in 60 seconds, hold for 240 seconds.
3. 1% ramp shear to 2% in 60 seconds, hold for 240 seconds.
4. 1% ramp shear to 3% in 60 seconds, hold for 240 seconds.
5. Shear sine wave amplitude 0.5% at frequencies: 0.01, 0.03, 0.1, 0.3, 1.0 Hz.
6. Shear goto Angle = 0. (note: this step is necessary to remain in the dynamic range of the
shear load cell).
lotal testing time: -35 min to setup and run protocol.
A.5.3. ANALYZING THE DATA
To extract the information from the .dyn files for mechanical properties calculations, a
macro was written in Visual Basic in Excel that copies the thickness, and "data" lines from the
output files into a separate spreadsheet. The program also calculates stiffness at each static step
and each frequency. It is then necessary to plot the static compression data as stress v. strain and
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calculate the slope of the line, which represents the stiffness of the sample, using linear
regression analysis.
Table A.2: Parameter order in "data" lines of IncuDyn output file. During application of
displacement, the IncuDyn measures and records parameters in a specified output file. This file
can be exported into Excel for data analysis.
StLafeLoadig . . Dynamic Lding
Date/Time 1 Date/Time
0 2 Frequency (Hz)
Time (seconds) 3 Static displacement (meters)
Displacement (meters) 4 Displacement amplitude (meters)
Load (grams) 5 Displacement phase angle
6 Total harmonic distortion of displacement
7 Static load (grams)
8 Load amplitude (grams)
9 Load phase angle
10 Total harmonic distortion of load
MACRO CODE: Written in VISUAL BASIC; runs in Microsoft Excel.
COMPRESSION:
Sub getData()
' run this macro from the data file (output as .dyn from IncuDyn) after first Inserting a blank worksheet in
front of data worksheet
' sample area is 7.07mm2
' in addition to copying data from the .dyn data file, macro also calculates the stiffness at each dynamic
frequency
' for static stiffness, will need to plot stress v. strain (calculated by this macro) and calculate slope (by
fitting a line to the data points)
' declares variables to be used as counters (i,j,k) and the samples thickness (thick)
I)im i As Integer
I)im j As Integer
I)im k As Integer
I)im thick
i = I
j i=l
k = 1
' loops through all lines of data in the output file - copies information of interest to worksheet 1
For i = 1 To 10000
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' copies thickness to worksheet 1 and sets variable "thick" equal to the sample thickness for later stiffness
calculations
If Worksheets(2).Cells(i, 1).Value = "thickness" Then
For k = 1 To 2
Worksheets(l).Cells(j, k)= Worksheets(2).Cells(i, k).Value
thick = Worksheets(2).Cells(i, k).Value
Next kj=j+l
' copies data measured at the end of static compression steps to worksheet 1
Elself Worksheets(2).Cells(i, 1).Value = "data" And Worksheets(2).Cells(i, 3).Value = "O" Then
For k = 1 To 5
Worksheets(l).Cells(j, k) = Worksheets(2).Cells(i, k).Value
Next k
Worksheets(l ).Cells(j, 6) = -Worksheets(l).Cells(j, 4) / thick
Worksheets(l).Cells(j, 7) = ((0.001 * 9.81) / (7.07 * 10 ^  -6)) * (Worksheets(l).Cells(j, 5).Value)j=j+1
' copies dynamic data for lowest frequency to worksheet 1 - need starting position data as final step of
static compression as well as frequency data at O.O1Hz
ElseIf Worksheets(2).Cells(i, 1).Value = "data" And Worksheets(2).Cells(i, 3).Value = "0.01" Then
Worksheets(l).Cells(j, 4)= Worksheets(2).Cells(i, 4).Value
Worksheets(l).Cells(j, 5) = Worksheets(2).Cells(i, 8).Value
Worksheets(l ).Cells(j, 6) = -Worksheets(l ).Cells(j, 4) / thick
Worksheets(l).Cells(j, 7) = ((0.001 * 9.81) / (7.07 * 10 ^ -6)) * (Worksheets(l).Cells(j, 5).Value)
j =j+ 1
For k = 1 To 11
Worksheets(l 1).Cells(j, k) = Worksheets(2).Cells(i, k).Value
Next k
Worksheets(l ).Cells(j,
Worksheets(1 ).Cells(j,
Worksheets(1).Cells(j,j=j+l
12) = Worksheets(l).Cells(j, 5) / (thick - Worksheets(l).Cells(j, 4))
13) = ((0.001 * 9.81) / (7.07 * 10 ^ -6)) * (Worksheets(l).Cells(j, 9).Value)
14) = Worksheets(l).Cells(j, 13) / Worksheets(l).Cells(j, 12)
'copies dynamic data for all higher frequencies
ElseIf Worksheets(2).Cells(i, 1).Value = "data" Then
Fork = 1 To 11
Worksheets(1).Cells(j, k) = Worksheets(2).Cells(i, k).Value
Next k
Worksheets(l).Cells(j, 12) = Worksheets(l).Cells(j, 5) / (thick - Worksheets(l).Cells(j, 4))
Worksheets(l).Cells(j, 13) = ((0.001 * 9.81) / (7.07 * 10 ^ -6)) * (Worksheets(l).Cells(j, 9).Value)
Worksheets(l).Cells(j, 14) = Worksheets(l).Cells(j, 13) / Worksheets(l).Cells(j, 12)j=j+l
End If
Next i
End Sub
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SHEAR:
Sub getShearData()
' run this macro from the data file (output as .dyn from IncuDyn) after first Inserting a blank worksheet in
front of data worksheet
' sample area is 4 times 7.07mm2 because four samples are tested at once in shear
' measurement assumes a 2.5in radius, because samples are at in from center, we divide by 2.5 to
account for this
' in addition to copying data from the .dyn data file, macro also calculates the stiffness at each dynamic
frequency
' for static stiffness, will need to plot stress v. strain (calculated by this macro) and calculate slope (by
fitting a line to the data points)
' declares variables to be used as counters (i,j,k) and the samples thickness (thick)
Dim i As Integer
Dim j As Integer
Dim k As Integer
I)irm thick
i = 1
j==1
' loops through all lines of data in the output file - copies information of interest to worksheet 1
For i = 1 To 16000
' copies thickness to worksheet 1 and sets variable "thick" equal to the sample thickness for later stiffness
calculations
If Worksheets(2).Cells(i, 1).Value = "thickness" Then
For k = 1 To 2
Worksheets(l).Cells(j, k)= Worksheets(2).Cells(i, k).Value
thick= Worksheets(2).Cells(i, k).Value
Next kj=j+1
' copies channel to worksheet 1 - this allows you to know what the fields in the data line refer to
(measured by torque load cell or compression load cell)
ElseIf Worksheets(2).Cells(i, 1).Value = "chan" Then
For k = 1 To 6
Worksheets(l).Cells(j, k) = Worksheets(2).Cells(i, k).Value
Next kj=j+1
'copies data measured at the end of static compression steps to worksheet 1
ElseIf Worksheets(2).Cells(i, 1).Value = "data" And Worksheets(2).Cells(i, 3).Value = "0" Then
For k = 1 To 5
Worksheets(l).Cells(j, k) = Worksheets(2).Cells(i, k).Value
Next k
Worksheets(l).Cells(j, 6) = Worksheets(l).Cells(j, 4) / (2.5 * thick)
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Worksheets(l).Cells(j, 7) = Worksheets(l).Cells(j, 5) / (0.0635 * 4 * 7.07 * 10 A -6)
Worksheets(l).Cells(j, 8) = Worksheets(l).Cells(j, 7) / Worksheets(l).Cells(j, 6)j=j+l
' copies dynamic data for lowest frequency to worksheet 1 - need starting position data as final step of
static compression as well as frequency data at O.O1Hz
ElseIf Worksheets(2).Cells(i, 1).Value = "data" And Worksheets(2).Cells(i, 3).Value = "0.01" Then
Worksheets(l).Cells(j, 4)= Worksheets(2).Cells(i, 4).Value
Worksheets(l).Cells(j, 5) = Worksheets(2).Cells(i, 8).Value
Worksheets(l).Cells(j, 6) = Worksheets(l).Cells(j, 4) / (2.5 *
Worksheets(l).Cells(j, 7) = Worksheets(l).Cells(j, 5) / (0.063:
Worksheets(l).Cells(j, 8) = Worksheets(l).Cells(j, 7) / Worksj=j+l
For k = 1 To 1
Worksheets(1).Cells(j, k) = Worksheets(2).Cells(i, k).Value
Next k
Worksheets(1).Cells(j, 12) = Worksheets(1).Cells(j, 5) / (2.5
Worksheets(l ).Cells(j, 13) = Worksheets(l).Cells(j, 9) / (0.06
Worksheets(1l).Cells(j, 14) = Worksheets(l).Cells(j, 13) / Woj=j+1
thick)
5 *4*7.07* 10 ^ - 6)
heets(1).Cells(j, 6)
* thick)
535 * 4 * 7.07 * 10 ^ -6)
rksheets(1).Cells(j, 12)
'copies dynamic data for all higher frequencies
ElseIf Worksheets(2).Cells(i, 1).Value = "data" Then
For k = 1 To 11
Worksheets(l).Cells(j, k) = Worksheets(2).Cells(i, k).Value
Next k
Worksheets(1).Cells(j, 12) = Worksheets(l).Cells(j, 5) / (2.5 * thick)
Worksheets(l).Cells(j, 13) = Worksheets(l).Cells(j, 9) / (0.0635 * 4 * 7.07 * 10 " -6)
Worksheets(l).Cells(j, 14) = Worksheets(l).Cells(j, 13) / Worksheets(l).Cells(j, 12)j=j+1
End If
Next i
End Sub
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SUPPLEMENTARY DATA
.B.1. REAL-TIME PCR GENE EXPRESSION DATA
B.1.1. GENE EXPRESSION IN CARTILAGE EXPLANTS FOLLOWING INJURIOUS
MECHANICAL COMPRESSION
-*- Fibronectin
- Fibromodulin
- Link Protein
Collagen I
--- Sox 9
0 6 12
Time (hours)
Figure B.1: Changes in expression level of matrix molecules (fibronectin, fibromodulin,
link protein), collagen I, and transcription factor sox 9 genes after injurious compression.
Values on the y-axis represent fold change from free swelling levels with a value of 1 indicating
similar expression after injury to the level measured in free swelling conditions. Six cartilage
disks were pooled for each time point for each experiment. All samples normalized to total RNA
at the reverse transcription step. Mean SE (n=3).
120
10
1
U)
I=
LU.
X
0.1
18 24
,APPENDIX :
I n_
1
U
X
0.1
0 6 12 18 24
Time (hours)
Figure B.2: Changes in expression level of matrix degrading molecules (MMP-1, MMP-9.
ADAMTS-4) and inhibitor (TIMP-2) genes after injurious compression. Values on the y-
axis represent fold change from free swelling levels with a value of 1 indicating similar
expression after injury to the level measured in free swelling conditions. Six cartilage disks were
pooled for each time point for each experiment. All samples normalized to total RNA at the
reverse transcription step. Mean + SE (n=3).
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B.1.2. GENE EXPRESSION IN CARTILAGE EXPLANTS DURING CO-CULTURE
WITH JOINT CAPSULE TISSUE
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Figure B.3: Changes in expression level of matrix molecules (fibronectin, fibromodulin,
link protein), and collagen I genes during co-culture with joint capsule tissue. Values on the
y-axis represent fold change from non-co-cultured levels with a value of 1 indicating similar
expression during co-culture to the level measured in control conditions. Six cartilage disks were
pooled for each time point for each experiment. All samples normalized to total RNA at the
reverse transcription step. Mean + SE (n=3).
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Figure B.4: Changes in expression level of matrix degrading molecule (MMP-9), and
inhibitors (TIMP-1, TIMP-2) genes during co-culture with joint capsule tissue. Values on
the y-axis represent fold change from non-co-cultured levels with a value of 1 indicating similar
expression following injury and co-culture to the level measured in control conditions. Six
cartilage disks were pooled for each time point for each experiment. All samples normalized to
total RNA at the reverse transcription step. Mean ± SE (n=3).
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B.1.3. GENE EXPRESSION IN CARTILAGE EXPLANTS FOLLOWING INJURIOUS
MECHANICAL COMPRESSION AND CO-CULTURE WITH JOINT CAPSULE
TISSUE
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Figure B.5: Changes in expression level of matrix molecules (fibronectin, fibromodulin,
link protein), and collagen I genes during co-culture with joint capsule tissue following
injurious mechanical compression. Values on the y-axis represent fold change from free
swelling, non-co-cultured levels with a value of 1 indicating similar expression following injury
and co-culture to the level measured in control conditions. Six cartilage disks were pooled for
each time point for each experiment. All samples normalized to total RNA at the reverse
transcription step. Mean + SE (n=3).
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Figure B.6: Changes in expression level of matrix degrading molecule (MMP-9), and
inhibitors (TIMP-1, TIMP-2) genes during co-culture with joint capsule tissue following
injurious mechanical compression. Values on the y-axis represent fold change from free
swelling, non-co-cultured levels with a value of 1 indicating similar expression following injury
and co-culture to the level measured in control conditions. Six cartilage disks were pooled for
each time point for each experiment. All samples normalized to total RNA at the reverse
transcription step. Mean + SE (n=3).
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B.2. INTERPRETATION OF RELATIVE GENE EXPRESSION LEVELS
adamts-4
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tnf-a
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c-jun
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P-actin
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Figure B.7: Free swelling expression levels of 24 genes ranked by relative abundance.
Expression levels were normalized to expression of ADAMTS-4, the least abundant gene
measured. Data are reported as Mean + SE (n = 3).
When comparing relative expression levels of different genes within a single cDNA
sample as was done here, it was assumed that the efficiencies of the primers for the different
genes had equal efficiencies. Standard curves were generated by Moonsoo Jin, Jon Fitzgerald,
and myself to quantify the efficiency of each primer used in our real-time PCR studies. We
determined that the efficiencies of each primer set were between 95% and 110%. When
interpreting the data presented in Figure B.7, it must be considered that this variation in primer
efficiencies will potentially result in low percentage inaccuracies in the reported level of
expression for each gene and should serve as a caveat for quoting exactly the levels of expression
reported.
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B.3. WESTERN BLOTS
B.3.1. WESTERN BLOT FOR AGGRECAN G1 DOMAIN ON CONDITIONED
MEDIUM IN INJURY MODELS
,full length
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Figure B.8: Conditioned medium analysis for aggrecan fragments with intact G1 domain
following treatment with IL-la, mechanical injury, or co-culture with joint capsule tissue.
Western blot for aggrecan using an anti-GI antibody (J. Sandy) in conditioned medium samples
from free-swell control (lane 1), IL-la (10 ng/ml) treated cartilage (lane 2), mechanically injured
cartilage (lane 3), mechanically injured cartilage co-cultured with joint capsule tissue (lane 4),
uninjured cartilage co-cultured with live (lane 5) or dead (lane 6) joint capsule tissue, live (lane
7) or dead (lane 8) joint capsule tissue cultured alone. Treatment with exogenous IL-la results in
abundant release of matrix protein aggrecan fragments to the culture medium. Joint capsule
tissue when cultured alone releases aggrecan protein fragments to the culture medium making
interpretation of cartilage degradation by examining culture medium alone inconclusive.
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B.3.2. WESTERN BLOT FOR AGGRECAN G3 DOMAIN ON CONDITIONED
MEDIUM IN INJURY MODELS
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Figure B.9: Conditioned medium analysis for aggrecan fragments with intact G3 domain
following treatment with IL-la, mechanical injury, or co-culture with joint capsule tissue.
Western blot for aggrecan using an anti-G3 antibody (J. Sandy) in medium from free-swell
control (lane 1), IL-lac (10 ng/ml) treated cartilage (lane 2), mechanically injured cartilage (lane
3), mechanically injured cartilage co-cultured with joint capsule tissue (lane 4), uninjured
cartilage co-cultured with live (lane 5) or dead (lane 6) joint capsule tissue, live (lane 7) or dead
(lane 8) joint capsule tissue cultured alone. Treatment with exogenous IL-l c results in abundant
release of matrix protein aggrecan fragments to the culture medium. Joint capsule tissue when
cultured alone releases aggrecan protein fragments to the culture medium making interpretation
of cartilage degradation by examining culture medium alone inconclusive.
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B.3.3. WESTERN BLOT FOR ADAMTS-5 ON CONDITIONED MEDIUM FROM
INJURY MODELS
80
'a 60
50
40
on
.JV
1 2 3 4 5 6 7 8 9 10
Figure B.10: Conditioned medium analysis for aggrecanase-2 (ADAMTS-5) following
treatment of cartilage with IL-la, mechanical injury, or co-culture with joint capsule
tissue. Western blot for aggrecanase enzyme, anti-ADAMTS-5 antibody (Wyeth Research, C.
Flannery) in medium from free-swell control (lane 1), IL- la (10 ng/ml) treated cartilage (days 1-
2 of treatment lane 2; days 3-4 of treatment lane 3), mechanically injured cartilage (lane 4),
mechanically injured cartilage co-cultured with joint capsule tissue (lane 5), uninjured cartilage
co-cultured with live (lane 6) or dead (lane 7) joint capsule tissue, live (lane 8) or dead (lane 9)
joint capsule tissue cultured alone, recombinant ADAMTS-5 (Wyeth Research; lane 10).
Treatment with exogenous IL- cla results in release of ADAMTS-5 by days 3-4 to the culture
medium. No enzyme was detected using Western blotting in any of the injury models tested due
to either lack of production of this enzyme in these models or an enzyme protein level below the
detection limit of the methods used.
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B.3.4. WESTERN BLOT FOR ADAMTS-4 ON CONDITIONED MEDIUM FROM CO-
CULTURE OF CARTILAGE WITH JOINT CAPSULE TISSUE
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Figure B.11: Conditioned medium analysis for aggrecanase-1 (ADAMTS-4) following
treatment of cartilage with IL-la or co-culture with joint capsule tissue. Western blot (non-
reducing conditions) for aggrecanase enzyme, anti-ADAMTS-4 antibody (C. Flannery) in
medium from free-swell control (lane 1), IL-la (10 ng/ml) treated cartilage (days 3-4 of
treatment; lane 2), uninjured cartilage co-cultured with live joint capsule tissue (lane 3), live joint
capsule tissue cultured alone (lane 4). Treatment with exogenous IL-1 results in release of
AI)AMTS-4 by days 3-4 to the culture medium. ADAMTS-4 was released to the medium from
joint capsule tissue cultured alone; no additional release of enzyme was seen for cartilage co-
cultured with joint capsule tissue. The high molecular weight band seen in the lanes containing
medium from culture of joint capsule tissue may be due to non-specific binding of either the
primary or secondary antibody to a protein present in the sample or may represent a high
molecular weight form of ADAMTS-4 possibly bound to another protein.
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B.4. ZYMOGRAMS TO MEASURE MMP-2, MMP-3, AND MMP-9 IN INJURY
MODELS
METHODS: Zymography was used to analyze the presence of pro- and active MMP-2, MMP-9,
and MMP-3 in culture medium following injurious mechanical compression and during co-
culture with joint capsule tissue. Equal volumes of culture medium were mixed with loading
buffer and electrophoresed under non-reducing conditions on a 10% SDS-polyacrylamide gel
containing gelatin (Bio-Rad, #161-1113) for detection of MMP-2 and MMP-9, or a 12% gel
containing casein (Bio-Rad, #161-1114) to identify MMP-3. Gels were washed 3 times for 20
minutes in 2.5% Triton X-100, rinsed in distilled water, then incubated in proteolysis buffer (50
mM Tris, 50 mM CaC12, 0.5 M NaCl, pH 7.8) for 16 hours on a shaker table at 370 C (Gilbert,
1997). Following proteolysis the gels were stained with 0.1% Coomassie Brilliant Blue R250 in
50% methanol for 1 hour and destained in 10% methanol, 7.5% acetic acid solution until bands
were visible. Pro- and active forms of MMPs were identified by molecular weight. As a control
experiment for activity on zymograms, 10 mM EDTA was added to the proteolysis buffer.
Absence of proteolytic activity with the addition of EDTA supports the conclusion that MMPs
are responsible for bands detected in the zymograms (Gilbert, 1997).
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Figure B.12: Casein zymograms on conditioned medium from cartilage explants following
mechanical injurious compression. Cartilage explants were either compressed to 50% strain at
a strain rate of 100%/s or maintained in free swelling control culture. A) Following compression,
explants were placed in fresh culture medium containing 10% fetal calf serum and cultured for
the time indicated. B) Following compression, samples were placed in fresh culture medium
containing 10% serum and 100 tg/ml cyclohexamide to block protein synthesis. The lack of an
upregulation in MMP-3 protein in the medium (as was seen in A) indicates MMP-3 released to
the medium following injurious compression was newly synthesized.
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Figure B.13: Zymograms on conditioned medium from cartilage explants during co-culture
with joint capsule tissue. Cartilage explants were either maintained in free swelling control
culture or co-cultured with a piece of joint capsule tissue for 24 hours. A) Casein zymogram
showing increased presence of MMP-3 in the culture medium during co-culture of cartilage with
joint capsule tissue. B) Gelatin zymogram showing increased presence of MMP-2 and MMP-9 in
the culture medium during co-culture of cartilage with joint capsule tissue.
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B.5. HYDROXYPROLINE CONTENT OF CARTILAGE EXPLANTS FOLLOWING
MECHANICAL INJURY AND CO-CULTURE WITH JOINT CAPSULE TISSUE
T TT
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Figure B.14: Hydroxyproline content of cartilage tissue explants following mechanical
injurious compression and co-culture with joint capsule tissue. Cartilage tissue explants were
subjected to mechanical injurious compression, co-culture with joint capsule tissue, or the
combination of mechanical injurious compression followed by co-culture with joint capsule
tissue. Tissue was digested with Proteinase K and OH-proline content of the digest was
measured by the hydroxyproline assay (Woessner, 1961; protocol from M. DiMicco). Mean + SE
(n=4).
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B.6. GENE EXPRESSION DATA CLUSTERED USING K-MEANS CLUSTERING
Performed in collaboration with Jonathan Fitzgerald.
B.6.1. CLUSTERING ANALYSIS OF GENE EXPRESSION PROFILES FROM
CARTILAGE EXPLANTS CO-CULTURED WITH JOINT CAPSULE TISSUE
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Figure B.15: Clustering analysis of gene expression in chondrocytes during co-culture of
cartilage explants with joint capsule tissue. Group expression profiles generated by k-means
clustering. The main temporal gene expression patterns induced by co-incubation of cartilage
explants with joint capsule tissue. Group profiles were calculated by averaging the expression
profiles of genes within each group.
Table B.1: Group members generated by k-means clustering. Temporal expression profiles
for each group shown in Figure B. 15.
GROUP 1
Fibronectin
Collagen I
Fibromodulin
1-actin
TIMP- 1
TNF-a
GROUP 2
Collagen II
Aggrecan
c-fos
c-jun
MMP-9
IGF-1
GROUP 3
MMP- 1
MMP-3
MMP-13
ADAMTS-4
ADAMTS-5
GAPDH
TIMP-2
IL-1ip
TGF-P
IGF-2
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13.6.2. CLUSTERING ANALYSIS OF GENE EXPRESSION PROFILES FROM
MECHANICALLY INJURED CARTILAGE EXPLANTS CO-CULTURED WITH
JOINT CAPSULE TISSUE
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Figure B.16: Clustering analysis of gene expression in chondrocytes during co-culture of
mechanically injured cartilage explants with joint capsule tissue. Group expression profiles
generated by k-means clustering. The main temporal gene expression patterns induced in
mechanically injured cartilage co-cultured with joint capsule tissue. Group profiles were
calculated by averaging the expression profiles of genes within each group.
Table B.2: Group members generated by
fbr each group shown in Figure B. 16.
k-means clustering. Temporal expression profiles
GROUP 2
Collagen II
Aggrecan
Fibromodulin
Fibronectin
Link Protein
Collagen I
MMP-1
MMP-9
MMP- 13
TNF-a
IL-1
GROUP 3
MMP-3
ADAMTS-4
ADAMTS-5
13-actin
TGF-P
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GROUP 1
GAPDH
TIMP-I
TIMP-2
GROUP 4
c-fos
c-jun
APPENDIX C: PRELIMINARY STUDIES
C.1. RNA ANALYSIS
Samples of RNA extracted from cartilage tissue were submitted for analysis on the
Agilent 2100 Bioanalyzer in the BioMicro Center at MIT to evaluate the extraction protocol
before beginning real-time PCR gene expression analysis in in vitro models of joint injury. The
Agilent Bioanalyzer measures the integrity/purity and concentration of RNA. Samples were
submitted twice with improvements made to the extraction protocol between submissions.
To improve the integrity of the RNA extracted from tissue samples, only two samples
were taken from the -80°C freezer at a time for pulverizing. After these two samples were
pulverized, they were returned to the freezer and the pulverizing equipment was re-frozen in
liquid N2 to ensure low temperature of the equipment while pulverizing all samples.
Additionally, RNA extraction was only performed for a total of four samples at a time. This was
done to reduce time for all steps throughout the extraction. Samples were spun on the benchtop,
also to save time in sample transfer between the centrifuge, rather than at 4°C as had been done
previously. The RNeasy kit was set-up before beginning extraction; -mercaptoethanol was
mixed with the RLT buffer. DNase was prepared for use before beginning extraction and kept on
ice so that it was ready when needed. An overall effort was made to work quickly and keep
samples at low temperature when possible.
Table C.1: Measurements of RNA concentration and purity. Samples were submitted to the
BioMicro Center at MIT to assess purity and degradation in samples of RNA extracted from
bovine articular cartilage. Improvements were made in the RNA extraction protocol to increase
yield and maintain RNA integrity for use in real-time PCR.
Sample submission Average concentration rRNA Ratio [28S/1 8S]
Initial 74 ng/tld 0.86
_fter improvements 100 ng/~tl 1.5
137
Improvements made to the extraction protocol resulted in an increase in the average
concentration of RNA obtained from each sample (Table C. 1). As well, the rRNA ratio increased
to be closer to the ideal value of 2.0 that represents intact RNA with minimal degradation.
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Figure C.1: Representative graph of Bioanalyzer data from initial submission of RNA to
the BioMicro center at MIT. Shows degradation of RNA in sample which appears as intensity
between the two peaks for 1 8s and 28s rRNA. Concentration: 52 ng/tl; rRNA ratio: 0.86.
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Figure C.2: Representative graph of Bioanalyzer data from second submission to the
BioMicro center at MIT after making improvements to the RNA extraction protocol. The
appearance of two peaks for rRNA with little intensity between the peaks signifies intact RNA.
Concentration: 79 ng/tl; rRNA ratio: 1.99.
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The concentration of RNA measured using the Agilent Bioanalyzer was in good
agreement with the concentration measured using the UV Spectrophotometer in the Grodzinsky
lab. After validating the quality of the RNA samples to be used for gene expression analysis
using real-time PCR in the BioMicro center, the UV Spec in the Grodzinsky lab was used to
measure RNA concentration and it was assumed that when the concentration of RNA was above
:55 ng/tl and the ratio of absorbance at 260 nm and 280 nm was above 1.7 that the RNA was of
suitable quality to use for gene quantification.
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C.2. WESTERN BLOTS (APMA AND ADAMTS-4 TREATMENTS)
Before beginning experiments to measure aggrecan degradation, it was necessary to
perform preliminary positive control studies to test the extraction protocol and antibodies being
used. With this aim, cartilage tissue samples were treated with recombinant ADAMTS-4 and
APMA. ADAMTS-4 was obtained from Wyeth research (C. Flannery) and cleaves aggrecan at
the 'aggrecanase site' at amino acid 373. Cleavage at this site results in a neo-epitope C-terminus
with sequence NITEGE (Caterson, 2000). The N-terminal fragment resulting from cleavage at
this site (G1-NITEGE) runs on SDS-page gels as a doublet with molecular weight between 60
and 80 kDa. APMA (aminophenylmercuric acetate) was obtained from Sigma-Aldrich and is a
known activator of matrix metalloproteinases (MMPs) which cleave aggrecan at the 'MMP site'
at amino 341. Cleavage at this site results in a neo-epitope C-terminus with bovine sequence
VDIPES (VDIPEN in human) (Caterson, 2000). The N-terminal fragment resulting from
cleavage at this site (G1-VDIPES) runs between 50 and 60 kDa on SDS page.
Cartilage explants were treated with 10 [tg/ml of ADAMTS-4 or 1 mM APMA for 16
hours. Aggrecan was extracted from the tissue and Western blotting performed as described in
A.4. AGGRECAN EXTRACTION, MEDIUM PREPARATION, AND WESTERN
BLOTTING.
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Figure C.3: Western blots for aggrecan fragments on tissue extracts from cartilage treated
with 10 [ig/ml recombinant ADAMTS-4 for 16 hours. Tissue extracts were run on 4-15%
gradient SDS-PAGE gels, transferred to nitrocellulose membranes, and immunoblotted with (A)
anti-G1, or (B) anti-NITEGE primary antibodies. Lanes 1-3 in A and 1-4 in B show cartilage
treated with ADAMTS-4; tissue extract from control (untreated) cartilage shown in lane 4 in A
and lane 5 in B.
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Figure C.4: Western blot for aggrecan fragments on tissue extracts from cartilage treated
with 1 mM AMPA to activate MMPs. Tissue extracts were run on 4-15% gradient SDS-PAGE
gels, transferred to nitrocellulose membranes, and immunoblotted with anti-G1 primary
antibody. Lanes 1-3 show cartilage treated with APMA; tissue extract from control (untreated)
cartilage shown in lane 4.
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APPENDIX D: GRODZINSKY LAB COLLABORATIVE PROJECTS
D.1. INVOLVEMENT OF ADAMTS-4 AND MT4-MMP IN AGGRECANOLYSIS OF
IL-1 TREATED BOVINE CARTILAGE (P. Patwari)
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Figure D.1: Real-time PCR analysis of ADAMTS-4 and ADAMTS-5. Cartilage disks were
incubated with no additives (control), 10 ng/ml IL-la (IL-1), 1.35 mM mannosamine (ManN), or
the combination (IL-1 + ManN). After 1 day of culture, mRNA was extracted and real-time PCR
was performed. Expression levels for (A) ADAMTS-4 and (B) ADAMTS-5 are shown relative
to untreated control disks for three replicate experiments as individual data points (circles) and
mean (bars). The effect of ManN, IL-1, and the interaction between ManN and IL-1 was tested
for significance by linear regression.
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D.2. EXPRESSION OF DEGRADATIVE ENZYMES IN A DYNAMICALLY
LOADED CHONDROCYTE-SEEDED PEPTIDE HYDROGEL (J. Kisiday)
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Figure D.2: Real-time PCR analysis of gene expression in dynamically loaded chondrocyte-
seeded peptide hydrogel. 1-2 week old bovine chondrocytes were seeded at 30x1 06 cells/ml into
0.36% self-assembling peptide scaffolds. Disks 1.6 mm thick, 12 mm diameter were punched
after seeding and maintained in free swelling culture for 12-14 days before loading. Dynamic
compression (2.5% strain amplitude, 0.3 Hz, 5% strain static offset) was applied in cycles of 4
repetitions of 45 min of loading/5 hr 15 min free swell followed by 24 hours without loading.
Control gels were maintained as parallel free swell cultures. Samples were frozen for PCR on
days 3 (light blue bars) and 13 (dark blue bars) within 30 min of the end of a loading cycle.
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Figure D.3: Free swelling expression levels of 24 genes ranked by relative abundance in
chondrocyte seeded peptide hydrogel. RNA was extracted from chondrocyte seeded self-
assembling peptide hydrogel following 15-17 days in free swelling culture. Expression levels
were normalized to expression of ADAMTS-4, the least abundant gene measured. Data are
reported as Mean _ SE for n = 2 replicate experiments using tissue from 3 different joints.
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D.3. ZYMOGRAPHY ON CONDITIONED MEDIUM SAMPLES IN
COLLABORATION WITH THE KURZ LAB (J. Fay, Kiel, Germany)
1 2 3 4 5 6 7 8
Figure D.4: Casein zymogram on conditioned medium from cartilage explants stimulated
with bacterial supernatants. Medium was collected from cartilage explant cultures after 48
hours of stimulation with staph aureus or pseudomonas aeroginosa either in the presence or
absence of superoxide-dismutase (SOD). Lanes: 1. Control; 2. Control + SOD; 3. Staph aureus
stimulation;; 4. Staph aureus + SOD; 5. Pseudomonas aeroginosa stimulation; 6. Pseudomonas
aeroginosa + SOD; 7. Pure (1:100) supernatant of Staph aureus; 8. Pure (1:100) supernatant of
IPseudomonas. Bands were between 66 kDa and 45 kDa molecular weight markers.
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Figure D.5: Gelatin zymogram on conditioned medium from cartilage explants stimulated
with bacterial supernatants. Medium was collected from cartilage explant cultures after 48
hours of stimulation with staph aureus or pseudomonas aeroginosa either in the presence or
absence of superoxide-dismutase (SOD). Lanes: 1. Control; 2. Control + SOD; 3. Staph aureus
stimulation;; 4. Staph aureus + SOD; 5. Pseudomonas aeroginosa stimulation; 6. Pseudomonas
aeroginosa + SOD; 7. Pure (1:100) supernatant of Staph aureus; 8. Pure (1:100) supernatant of
Pseudomonas. Bands were between 66 kDa and 45 kDa molecular weight markers.
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APPENDIX E: CENTOCOR COLLABORATIVE PROJECTS
All experiments were designed, performed, and analyzed with Mike DiMicco.
It has been shown previously that IL-1 and TNF-cc interact with mechanical injury of
bovine and human cartilage, inducing a synergistic release of GAG from the cartilage to the
medium (Patwari, 2003). Likewise, it has been reported these cytokines act synergistically with
I[L-6/sIL-6R to induce greater GAG release from bovine cartilage than treatment with either IL-
l cc or TNF-cc (Flannery, 2000; Rowan, 2001). Experiments described in this Appendix were
designed to test if the combination of mechanical injury, IL-1/TNF, and IL-6 result in additional
synergistic responses in release of GAG to the medium or altered biosynthesis rates and to test if
co-culture with joint capsule tissue is affected by addition of exogenous IL-6 or IL-6 blockade.
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E.1. INTERACTION BETWEEN IL-1, IL-6, AND MECHANICAL INJURY
Table E.l: Description of sample treatment groups to test for interactions between IL-6,
IL-la, and mechanical injurious compression.
Group n IL-6/sIL-6R, IL-la, injury
50/250 ng/mL 1 ng/mL
C 4 no no
B 4 ??? ;! 'ii <: , no
C 4 I,, iy !
E 4 no no no
F 4 no . no
G 4 no no
H 4 I no
V
CD
0
Cu
0
%total
GAG
44
35
27
18
9
pg/ pgl
plug mg ww
177 25
141 20
106 15
71 10
35 5
0 0 0
IL-6/slL-6R + + + *l + +
IL-la + + + +
injury + +
Figure E.A: Cumulative GAG released to the medium during six days in culture with
combinations of exogenous IL-6, IL-la, and mechanical injurious compression. Various
units are plotted on the y-axis for comparison to previously published work. Mean+SE, n=3-4.
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Figure E.2: Biosynthesis rates on days 5-6 in response to treatments with exogenous IL-6,
IL-la, and mechanical injurious compression. Mean+SE, n=3-4.
Treatment with IL-6/sIL-6R alone had no effect on GAG release, GAG biosynthesis, or
protein biosynthesis, evaluated by comparing groups E and G. This lack of IL-6/sIL-6R effect on
GAG release is in agreement with Flannery, 2000. Treatment with IL- la resulted in 50% GAG
release over the 6-day culture, and reduced sulfate (-21%) incorporation, with no effect on
proline incorporation. Addition of injury did not affect the total GAG release from injured
cartilage samples cultured in the presence of IL-6/sIL-6R for 6 days, but it did reduce both the
proline and sulfate incorporations compared to treatment with IL-6/sIL-6R alone. The
combination of IL-la and IL-6/sIL-6R increased GAG release over either cytokine separately;
this increase appeared to be more than additive in agreement with Flannery, 2000. There also
appeared to be a synergistic reduction in sulfate and proline incorporations, which has not been
previously reported. The addition of injury, however, did not appear to further increase the GAG
release over treatment with the two cytokines, though injury further reduced both proline and
sulfate incorporation.
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There are two novel findings in this study. The first is that IL-la and IL-6 act
synergistically to reduce GAG and protein biosynthesis, in addition to the synergistic increase in
GAG release previously observed, and seen again here. The second novel finding is that in
contrast with previous studies where IL-la and injury acted synergistically to increase GAG
release, there was no such interaction in the presence of IL-6 and its soluble receptor (however,
injury did further decrease both proline and sulfate incorporation compared with IL-I+IL-6-
treated samples). Since this experiment did not compare samples injured with IL-la and IL-
6/sIL-6R to samples injured in medium with only IL-la, it is not possible to conclusively
determine that IL-6 interfered with the IL-l a/injury synergy, but it may be interesting to pursue
this finding in future studies.
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E.2. INTERACTION BETWEEN TNF-a, IL-6, AND MECHANICAL INJURY
Table E.2: Description of sample treatment groups to test for interactions between IL-6,
TNF-a, and mechanical injurious compression.
Group n IL-6/sIL-6R, TNF-a, injury
50/250 ng/mL 100 ng/mL
A 4 no no
B 4 no
C 4 o no
D 4 _
E 4 no no no
F 4 no no
G 4 no no
H 4 f no
IL-61 slL-6R
TNF.a :
injury
mean ± SEM, n=4
* Day 0-2
[O Day 2-4
o Day 4-6
A
*l 
+)
U
. + .
: '
Figure E.3: Cumulative GAG released to the medium during six days in culture with
combinations of exogenous IL-6, TNF-a, and mechanical injurious compression. Mean+SE,
n=4.
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Figure E.4: Biosynthesis rates on days 5-6 in response to treatments with exogenous IL-6,
TNF-a, and mechanical injurious compression. Mean+SE, n=4.
Treatment with IL-6/sIL-6R alone did not result in a significant release of GAG or
change in proline incorporation but did reduce sulfate incorporation by 10% (p<0.05). Treatment
with TNF-ca significantly increased GAG release by 57% over controls (p < 0.005) and
decreased proline and sulfate incorporation. Analysis by 2-way ANOVA (E, F, G, H) revealed
significant effects of treatment with TNF-c (p < 0.001) and IL-6 (p < 0.005) on proline
incorporation rate; there was also a significant interaction between the two cytokines (p < 0.01).
Treatment with both cytokines resulted in GAG release that was higher than either IL-6 alone
(by 120%, p < 0.001), or TNF-a alone (by 43%, p < 0.01). Addition of injury did not affect the
total GAG release from injured cartilage samples cultured in the presence of IL-6 (p = 0.5). In
the presence of IL-6, analysis by 2-way ANOVA indicated that there was a significant effect of
treatment with TNF-a (p < 0.001), but no effect of injury (p = 0.08), and no interaction (p =
0.15). Treatment with TNF-ca and injury was higher than injury alone (by 186%, p < 0.001), but
was not higher than TNF-a alone (p=0. 12).
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The main objective of this experiment was to investigate the effect of including injury
with cytokine treatments. In the presence of IL-6, the addition of injury did not affect GAG
release. Furthermore, the increase in GAG release with IL-6, TNF-a, and injury can be attributed
to the presence of TNF-ca, since there was no main effect of injury (p = 0.08), nor an interaction
between injury and TNF-a (p=0. 15) in the presence of IL-6.
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E.3. INTERACTION BETWEEN CO-CULTURE, IL-6, AND MECHANICAL
INJURY
Table E.3: Description of sample treatment groups to test for interactions between IL-6, co-
culture with joint capsule tissue, and mechanical injurious compression.
Group n IL-6/sIL-6R, joint injury
50/250 ng/mL capsule
A 4 no no
B 4 _ i no
C 4 . ii no y
D 4
E 4 no no no
F 4 no no
G 4 W no no
H 4 f no
80
>, 3 60
v -Io
L.
o '= 40U 40
Co
E 20
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Figure E.5: Proline incorporation rate on days 5-6 in response to treatments with
exogenous IL-6, co-culture with joint capsule tissue, and mechanical injurious compression.
Mean+SE, n=4.
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Figure E.6: Sulfate incorporation rate on days 5-6 in response to treatments with
exogenous IL-6, co-culture with joint capsule tissue, and mechanical injurious compression.
Mean+SE, n=4.
Treatment with IL-6/sIL-6R alone was assessed by comparing groups E and G, which
were not significantly different in sulfate incorporation (p = 0.84) or proline incorporation (p =
0.59). Co-culture of cartilage with joint capsule tissue significantly decreased sulfate
incorporation by 70% (p < 0.005), and proline incorporation by 65% (p < 0.005). Analysis by 2-
way ANOVA (E, F, G, H) revealed no significant main effects of treatment with IL-6 on sulfate
or proline incorporation (sulfate p=0.95, proline p=0.66). The effect of co-culture was significant
(p<0.001 on both proline and sulfate incorporation). There was no significant interaction
between IL-6 and co-culture on biosynthesis rates (proline p=O. 15, sulfate p=0.28). Addition of
inj ury did not affect the rate of proline incorporation in injured cartilage samples cultured in the
presence of IL-6 (p = 0.78). However, there was a significant reduction in sulfate incorporation (-
60%; p < 0.02). In the presence of IL-6, analysis by 2-way ANOVA indicated that there was a
significant effect of co-culture on proline incorporation (p < 0.001), but no effect of injury (p =
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0.36), and no interaction (p = 0.71). Both injury and co-culture affected sulfate incorporation,
with no interaction (p=0.06).
The main objective of this experiment was to investigate the effect of including injury
with co-culture and IL-6/sIL-6R treatments. In the presence of IL-6, the addition of injury
significantly reduced sulfate incorporation as did co-culture with joint capsule. However there
was no significant interaction between injury and co-culture in the presence of IL-6 on sulfate
incorporation (p=0.06). Furthermore, the decreased proline incorporation with IL-6, co-culture,
and injury can be attributed to the presence of joint capsule tissue, since there was no main effect
of injury (p = 0.36), nor an interaction between injury and co-culture (p>0.71) in the presence of
IL-6.
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E.4. INTERACTION BETWEEN IL-6 AND MECHANICAL INJURY
Table E.4: Description of sample treatment groups to test for interactions between IL-6
and mechanical injurious compression.
Group n IL-6/sIL-6R, injury
50/250 ng/mL
A 4 no no
B 4 no
C 4 no
D 4
0
CD0
0)
0
(DL-
C,
%total
GAG
14
pg! pg/
plug mg ww
o00 01
10 42 6
7 28 4
3.5 14 2
0 n nl
T
IL-6/slL-6R
injury
-I
+
+
+
Figure E.7: Cumulative GAG released to the medium during six days in culture with
combinations of exogenous IL-6 and mechanical injurious compression. Mean+SE, n=4.
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Figure E.8: Biosynthesis rates on days 5-6 in response to treatments with exogenous IL-6
and mechanical injurious compression. Mean+SE, n=4.
GAG release to the culture medium was measured over the 6 day culture period. As
observed previously, the cumulative GAG release from injured samples was nearly identical to
that from uninjured samples. Addition of IL-6/sIL-6R at 50/250 ng/ml had no effect on GAG
release from free swelling controls and did not increase GAG release from injured samples.
Mechanical injury resulted in an approximately 40% decrease in sulfate incorporation;
injury had no effect on proline incorporation in this study. There was no apparent effect of IL-
6/sIl-6R treatment on biosynthesis rates.
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E.5. EFFECT OF IL-6 BLOCKADE ON CO-CULTURE OF CARTILAGE WITH
JOINT CAPSULE TISSUE
'Table E.5: Description of sample treatment groups to test for an effect of IL-6 blockade on
the reduction in biosynthesis observed during co-culture with joint capsule tissue.
Group n joint IL-6
capsule mAb
A 4 no no
B 4 .'1 no
C 4 no
D 4
125 -
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Figure E.9: Proline incorporation rate on days 5-6 during co-culture with joint capsule
tissue and treatment with a monoclonal antibody to IL-6. Mean-SE, n=4.
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Figure E.10: Sulfate incorporation rate on days 5-6 during co-culture with joint capsule
tissue and treatment with a monoclonal antibody to IL-6. Mean-SE, n=4.
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Treatment with IL-6 mAb alone did not affect sulfate incorporation or proline
incorporation. Co-culture of cartilage with joint capsule tissue significantly decreased sulfate
incorporation by 71%, and proline incorporation by 67%. Addition of the IL-6 mAb to cartilage
co-cultured with joint capsule resulted in a slight block of the biosynthesis reduction seen for co-
culture alone (sulfate to 63% reduced compared to 71% for co-culture alone; proline to 55%
reduction compared to 67% for co-culture alone).
The IL-6 mAb showed a partial restoration of biosynthesis levels of both proline and
sulfate toward levels seen in control cartilage. A second set of experiments was carried out to
increase the concentration of IL-6 mAb and test for more complete restoration of biosynthesis.
Experiments were also performed in which the IL-6 Fab fragment to block IL-6 was used in
place of the full-length mAb.
Table E.6: Description of sample treatment groups to test for an effect of IL-6 blockade
with full length antibody or Fab fragment on reduction in biosynthesis observed during co-
culture with joint capsule tissue.
Group n joint anti-IL-6 anti-IL-6
capsule mAb Fab
[g/mL] [g/mL]
A 4- 
B 4 yes - -
C 4 yes 10
D 4 yes 100 -
E 4 yes 500
F 4 yes 4
G 4 yes 40
H 4 yes 200
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Figure E.11: Biosynthesis rates on days 5-6 during co-culture with joint capsule tissue and
treatment with either a full length monoclonal antibody to IL-6 or the Fab fragment of the
IL-6 antibody. Mean+SE, n=4.
Table E.7: Properties of IL-6 blocking antibodies provided by Centocor.
Parameter anti IL-6 mAb Fab 136
molecular mass (by 148 kDa 48 kDa
SDS-PAGE)
EC 50 vs 500 pg/mL 3.4 pM 8.5 pM
rhIL-6 (50 ng/mL) (41 ng/mL)
The presence of joint capsule in the same culture well with cartilage explants caused a
-80% reduction in both proline and sulfate biosynthesis, compared with cartilage cultured
without joint capsule tissue present in the well. It had been previously determined that there was
no effect of IL-6 mAb treatment alone on either proline or sulfate biosynthesis at 10 tg/mL. In
the present experiment, the concentration of mAb was increased 10-fold and 50-fold, and in
neither case was there an effect on the joint capsule-induced reduction of biosynthesis. To test
whether the efficacy of IL-6 blockade in this system was related to the penetration of the large
mAb molecules into cartilage during culture, we also tested solutions containing the smaller Fab
136 fragment of the anti-IL-6 mAb. At concentrations of 5, 40, or 200 ~tg/mL, there was no
effect on the capsule-induced reduction in biosynthesis.
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As has been seen previously, the co-culture of joint capsule tissue with cartilage is a
potent inhibitor of chondrocyte biosynthesis. This experiment verified that using relatively high
concentrations of anti IL-6 monoclonal antibodies, or their Fab fragments, had no effect on the
reduction of biosynthesis in this model system.
Although it was not known whether IL-6 was involved in the biosynthesis effects
observed with joint capsule co-culture, it is apparent that a soluble factor is involved that either
directly or indirectly results in this reduction:
· A direct mechanism implies that a soluble factor acts directly on the cartilage, inducing
a reduction in biosynthesis. Based on our previous experiments, in which IL-6 and its
soluble receptor were added directly to the culture medium, this cytokine alone does not
cause a change in biosynthesis, and therefore is not a direct mediator of this biosynthesis
reduction (however, the fact that it interacted with exogenous recombinant IL-la and
TNF-a to induce a synergistic GAG release implies that the recombinant human proteins
are active in a bovine tissue system). Moreover, the concentrations of antibodies used
here were up to 10,000 times higher than the EC50 values quoted from Centocor for cell-
based assays. At these high concentrations, the antibodies should be more than sufficient
to bind any IL-6 in solution released from the joint capsule before it reaches the cartilage.
* An indirect mechanism of action would involve a soluble factor from the capsule
inducing the production of one or more other molecules by chondrocytes, and it is these
induced molecules that exert the inhibitory effect. If IL-6 were among these induced
molecules, the neutralizing antibodies would need to be present within the tissue, at the
cells, so that they could intercept the IL-6 before it could exert an effect. It is possible
that at 48 kDa, even the Fab fragment is not sufficiently small to penetrate the cartilage
matrix to a meaningful extent.
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Finally, a recurring problem in the analysis of these experiments is the issue of cross-
species reactivity between the tissue and any induced molecules (bovine), antibodies and their
firagments (anti-human), and in previous studies, exogenous cytokines (human). It is possible that
the antibodies used here do not recognize the bovine protein, and therefore, are not able
neutralize it. Indeed, the sequence homology between bovine and human IL-6 is approximately
49%, and there are few long homologous stretches within the molecule. If the antibody and
protein do not cross-react, bovine IL-6 in the culture medium (from the capsule) could not be
bound by the antibody, and even if the Fab fragment could penetrate the cartilage, it would be
unable to neutralize any processes dependent on induced IL-6.
In summary, the antibodies used here should be present at high enough concentrations to
neutralize IL-6 dependent processes. That no effect was observed means that at least one of the
following is true:
* IL-6 is not involved in the co-culture induced biosynthesis reduction
* The antibodies do not penetrate the cartilage, and therefore are ineffective against
induced IL-6 activity
* The antibodies do not recognize bovine IL-6, and therefore have no activity in this
system
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